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Abstract 
One question central to the study of developmental biology is: How does 
phenotypic diversity arise? The neural crest provides an excellent model system for 
investigations into the nature of cell-fate decisions and generation of lineage diversity. 
In the studies described here, I have examined two aspects of this question in cell 
culture. The ftrst aspect concerns the cellular dynamics underlying the cell-fate 
decisions. A necessary prerequisite to the study lineage diversification is the reliable 
production of differentiated cells from undifferentiated precursors in a controllable 
environment. I have developed a system for the growth of rat neural crest cells. The 
system allows the serial propagation of a defined sub-population of neural crest cells at 
clonal density. In the system neural crest cells can differentiate into at least two 
identifiable cell types; peripheral neurons and Schwann cells. By sub-cloning I have 
been able to address specific predictions made by a stem cell model of neural crest 
development, and found neural crest cells to possess multipotency, self-renewal and the 
capacity to divide asymmetrically. 
The second aspect of the question addressed in this study concerns the ability of 
the neural crest cell environment to control the choice of cell fate. I have examined 
various culture conditions for their ability to affect the choice of cell fate both in clonal 
cultures and in mass cultures. In the clonal cultures I found that the fate of neural crest 
cell clones can be altered in an instructive fashion by the composition of the substrate, 
or by the presence of fetal bovine serum. In mass cultures, we have examined the 
effect of medium composition on the expression of adrenergic traits and on the 
expression of a transcription factor, MASH-1 , thought to participate in neural 
determination. Finally, in mass cultures of neo-natal adrenal chromaffin cells, we have 
examined the effects of basic fibroblast growth factor on neuronal differentiation, 
mitosis and acquisition of trophic dependence. 
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CHAPTER 1. Introduction 
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The neural crest is an unusual entity. A uniquely vertebrate structure, its 
appearance during evolution correlates roughly with the transition from filter-feeding to 
active predation. The neural crest provides a number of characteristics that make active 
predation possible. For fish it provides the gill structure to the pharynx allowing gas 
exchange. The neural crest provides the gnathal animal with teeth and facial bone with 
which the animal can capture and chew its prey. In addition the crest provides the 
enteric and autonomic nervous system with which digestion can be controlled (Gans 
and Northcutt, 1983; Northcutt and Gans, 1983). The neural crest fails to fall 
conveniently into a classical germ layer. It shares properties with both ectoderm and 
mesoderm. The neural crest, like ectoderm, produces neuronal, glial, and dermal 
elements. Like mesoderm, however, it produces bone, muscle, vascular structures and 
cartilage. Mesenchymal neural crest cells are unique in that they are not restricted to a 
germ layer during gastrulation. To distinguish neural crest mesenchyme from true 
mesoderm or ectoderm, investigators have named the tissue ectomesenchyme or 
mesectoderm (Le Douarin, 1982). The neural crest comprises a set of migratory 
precursor cells that originate from virtually every axial level of the neural folds. The 
neural crest cells individualize, emigrate from the dorsal neural tube at about the time of 
neural tube formation, and migrate throughout the developing embryo. Problems 
posed by neural crest development are common to much of developmental biology. 
How are neural crest cells induced to migrate and what pilots them to appropriate 
locations in the embryo? How do neural crest cells interact with other embryonic tissue 
to produce mature tissues? And, how are individual neural crest cell fates controlled? 
The focus of this discussion will be the latter of these questions. A necessary 
prerequisite for the examination of cell fate choices is to map the fate and to establish 
the developmental potential of the tissue. 
Mapping of neural crest cell fate 
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Early investigations into the development of the neural crest concerned the 
mapping of its contribution to mature structures in the animal. In these early studies, 
performed on amphibia and avians, the fate of neural crest cells was mapped chiefly 
using histological marking and surgical techniques (Horstadius, 1950). In some 
studies, investigators marked regions of the neural crest by focal applications of vital 
dyes. The fate of the marked regions could be followed until the concentration of the 
dye in the marked cells became undetectably low. Using [3H]thymidine to label donor 
tissue, Weston was able to map neural crest fates by grafting tissue between animals of 
the same species (Weston, 1963). In other studies, by removal of the neural crest or 
dorsal neural tube, the contribution of the neural crest to mature structures was inferred 
by the failure of those structures to form (Harrison, 1924). Interspecific grafts 
between closely related animals have also been used. In such studies grafted cells are 
easily distinguishable by cytological characteristics. These characteristics are stable and 
allow contributions to mature structures to be mapped at any point during development. 
Perhaps the most widely employed marker system of this type is the quail-chick 
chimera system of Le Douarin (Le Douarin, 1982). In the quail-chick system tissue can 
be transplanted from a quail embryo to a chicken embryo and allowed to develop. 
Tissue from the two sources can be easily distinguished because the nucleoli of the two 
species possess distinct structures that can be easily discriminated by histological 
staining. One of the most striking features of the neural crest to emerge from these 
studies is the diversity of derivative cell types produced. The neural crest produces 
virtually all the peripheral nervous system, all the melanocytes of the skin, the bone, 
cartilage, and some muscle of the face. The neural crest produces important structural 
elements of the cardiac outflow tract. The neural crest also produces the endocrine cell 
types such as epinephrine producing chromaffin cells of the adrenal medulla and the 
calcitonin producing C-cells of the thyroid gland. 
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The studies described above provide important information concerning the fate 
of populations of neural crest cells. It is important, however, to realize the limitations 
of each type of marking study. The most extensive mapping of avian neural crest cell 
fate has been carried out using the quail-chick marker system. The primary concern 
with this mapping technique is that it is an interspecific grafting technique. Quail 
embryos are smaller and develop more quickly than chicken embryos. When the neural 
crest begins its migration, however, embryos are remarkably similar in size and at a 
given temperature develop to the same stage within a few hours of each other. 
Chimeric structures that form, however, are apparently normal in terms of the cell types 
that form and the timing of development (Le Douarin, 1982). Another problem arises 
in the post-hatching chimera. In attempts to construct brain chimera to study species-
specific behaviors, investigators found that the chimeras became sick a few weeks after 
hatching (Kinutani et al., 1986; Kinutani et al., 1989). At that time the host immune 
system becomes fully developed and does not recognize that grafted quail tissue as 
"self," thus an immune response is mounted against the grafted tissue. In the case of 
spinal cord grafts the graft rejection begins in the form of central nervous system 
demyelination in the grafted region that then spreads to the host tissue. A solution to 
this problem was eventually found by grafting a piece of quail thymic rudiment into the 
host chicken thymus (Ohki et al., 1987; Balaban et al., 1988; Ohki et al., 1988). More 
relevant to embryological studies is another potential problem. It has been suggested 
that quail neural crest cells may be more invasive than the corresponding chicken neural 
crest cells (Bellairs et al., 1981; Serbedzija et al., 1991). If this is true then a 
transplantation study may actually reveal a latent potential of the quail neural crest cells, 
rather than the fate normally expressed by the chicken cells. This possibility motivates 
the use of marking techniques wherein either no transplantation is used or the 
transplanted tissue is from the same species. 
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Problems associated with interspecific grafting are avoided if the fate mapping 
is performed by labeling cells with a vital marker. These techniques have the advantage 
that the same species of animal may be used. In general, fate mapping results obtained 
from labeling experiments support the results generated by chimeric studies. In 
addition vital labeling techniques can make it possible to study neural crest cell fate in 
animals that lack an established interspecific grafting technique. By injecting the vital 
fluorescent dye Dil into the lumen of the neural tube of embryonic mice, Serbedzija et 
al., were able to define pathways of neural crest cell migration in the mouse (Serbedzija 
et al., 1990). In addition, they were able to determine the sacral neural crest 
contribution to the enteric nervous system in both the chick and the mouse (Serbedzija, 
et al., 1991). Prior to this result there was some controversy concerning the sacral 
neural crest contribution to the enteric nervous system. The neural crest cell labeling 
allowed Serbedzija et al. , to demonstrate directly the neural crest cell contribution to the 
enteric nervous system without the worry that quail cells might be more invasive and 
infiltrate the gut in an inappropriate fashion. A drawback of these techniques, 
however, is that the label will be diluted as the marked cells divide. This opens the 
possibility that some of the progeny of the originally marked tissue will not be seen at 
the time of analysis. In effect, this limits the amount of time that development can 
proceed before the embryos must be analyzed. Other caveats associated with this 
technique will be explored further below. 
Bronner-Fraser and Fraser have extended the labeling technique to the level of 
single neural crest cells (Bronner-Fraser and Fraser, 1988; Bronner-Fraser and Fraser, 
1989; Fraser and Bronner-Fraser, 1991). Single pre-migratory or migrating avian 
truncal neural crest cells were injected with lysinated rhodamine dextran (LRD). 
Embryos were allowed to develop for 2 days then were fixed, sectioned and analyzed. 
The most striking result of these studies is that some single neural crest cells were 
found to produce diverse progeny in virtually every neural crest derived structure at that 
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axial level. Furthermore, those clones apparently comprised neurons, melanocytes, 
Schwann cells and satellite cells. The conclusion that the clones are multi potent, 
however, should be viewed with some caveats. Specifically, the only molecular 
marker of differentiation that was used was neurofilament (NF), which will recognize 
only neuronal cells. The phenotype of non-neuronal cells was inferred from their 
location and morphology. It remains possible that non-neuronal cells present in the 
ganglia represent neuronal precursors that have not yet undergone neuronal 
differentiation, or cells that have migrated inappropriately and are destined to die. 
Without a molecular marker for glia, it may be incorrect to conclude that non-neuronal 
cells in a ganglion are glia. The same caveat holds for the cells found in the dorsolateral 
pathway of migration. Without the observation of melanocyte differentiation it may be 
incorrect to conclude that those cells are melanocyte precursors. They could be cells of 
another phenotype that simply have migrated to an inappropriate location. 
Another caveat concerns the timing of the analysis. The embryos were injected 
at -stage 11-13, corresponding to -2 days of incubation, and analyzed 2 days later, 
which corresponds to -stage 22-24 (Hamburger and Hamilton, 1951). Given the 
constraint that the label will be present through only a limited number of cell divisions, 
it is understandable that the injected animals were only allowed to develop for 2 
additional days. The timing of neuron and glial birth, however, is such that 2 days may 
not be enough time to see all of the clonal progeny divide that normally would. 
Neurons are born until -stage 30 and glia are produced until at least -stage 36, 
corresponding roughly to day 7 and day 10 respectively (see description by Frank and 
Sanes, 1991). Finally, concerning timing, it remains possible that clones producing 
neurons in both dorsal root ganglia (DRG) and sympathetic ganglia (SG) may actually 
be producing neurons of only one phenotype in two different locations, and that given 
enough time the neurons inappropriate for their locations may be eliminated by 
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selection. The frrst timing caveat is addressed somewhat by lineage tracing studies of 
Frank and Sanes (Frank and Sanes, 1991). 
Frank and Sanes injected dilute solutions containing replication deficient 
retroviruses into the lumen of -stage 11 neural tube. Viruses infected neural tube cells 
including pre-migratory neural crest cells. The viruses were dilute enough that< 4 
infection events occurred per neural tube injection. They employed a mixture of two 
types of virus; one virus containing a gene encoding normall3-galactosidase and 
another virus containing a modified 13-galactosidase with a nuclear localization signal. 
Cells infected with the two viruses can be easily distinguished by the localization of the 
marker gene product. By using the mixture of viruses they were able to argue that 
cohorts of cells labeled in the same way represented clones, that is, they were progeny 
of the same founder cell. Because the retroviruses integrate into the host cell genome, 
the 13-galactosidase expression is a heritable trait whose expression is not necessarily 
lost through rounds of cell division. Hence, the marker can be detected at any point in 
development. Frank and Sanes were able to allow the injected embryos to develop 
beyond the time of significant neuron birth, i.e., to -stage 31-34. They considered 
only the DRG and found that a large fraction of the clones contained only neurons, as 
marked by the expression of long processes. The most common clone, however, 
contained a mixture of neurons and non-neuronal cells. The most phenotypically 
diverse clones contained the highest numbers of cells. The morphological criterion for 
neuronal differentiation precludes the need for a molecular marker of differentiation for 
neurons (although different types of neurons may not be distinguished), but the 
morphology of non-neuronal cells found in the DRG and nerve roots is not sufficient 
evidence to conclude that those cells have undergone glial differentiation. The fact that 
the embryos were fixed after most neuronal differentiation has taken place supports the 
notion that non-neuronal cells, if they are not actually glia, may eventually produce glia. 
It is possible, however, that the non-neuronal cells are undifferentiated progenitors. 
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Fate mapping studies using populations of neural crest cells reveal that the 
neural crest produces a diverse array of differentiated phenotypes. Fate mapping of 
single neural crest cells reveals, with a few caveats, that at least some multipotent neural 
crest cells exist. These studies do not necessarily reveal the developmental potential of 
the neural crest at the level of either single cells or populations of cells, because it is 
possible that some multi potent cells in such an experiment, will not experience the 
embryonic environment necessary to reveal their total developmental potential. The 
growth of neural crest cells in clonal culture has allowed a more complete examination 
of the multipotency of individual cells. 
The development of single cells from the neural crest and some of its derivative 
structures has also been studied in tissue culture. Several groups have grown clones of 
neural crest cells. In an early study of Sieber-Blum and Cohen, neural crest cells taken 
from 18 hour old neural tube outgrowths of 2-day old quail embryos produced large 
clones of 3 measurable phenotypes (Sieber-Blum and Cohen, 1980). Some clones 
contained only melanocytes, another group was composed only of non-pigmented cells 
and a third group contained mixtures of both melanocytes and non-pigmented cells. In 
addition some of the non-pigmented cells expressed formaldehyde-induced 
fluorescence (FIF), a characteristic of adrenergic cells. In more recent studies, Baroffio 
et al., cultured single primary cephalic neural crest cells onto feeder layers of growth 
arrested 3T3 cells (Baroffio et al., 1988). These investigators, using several antigenic 
markers to analyze clone composition, found a variety of phenotypes among clones. 
For example, they found some clones that contained only Schwann cells, as defined by 
expression of Schwann cell myelin protein (SMP) (Dupin et al., 1990). They also 
found clones that expressed virtually all of the markers that they tested including: 
substance-P (SP), which is expressed by some sensory neurons in vivo; tyrosine 
hydroxylase (TH), marking adrenergic differentiation; melanin, indicating melanocyte 
formation; and toluidine blue staining, which when done at pH 4.0 indicates cartilage 
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formation (Baroffio et al., 1991). There are two key results that one can draw from 
these studies. First, there exist some cells in the neural crest that are able to produce 
cells of virtually every measurable neural crest derivative, i.e., multi potent cells. Thus, 
the multi potency of the neural crest as a whole can be explained by the multi potency of 
many individual neural crest cells, consistent with the in vivo studies. Moreover, since 
a number of molecular marker of different neural crest lineages were examined, the fact 
of multi potency of neural crest cell is more firmly established in these studies than in 
the in vivo studies. Second, under conditions that allow multipotent cells to express 
their multipotency, some crest cells appear to be committed to form only a single 
phenotype. 
Multipotency is manifest in the clonal cultures as clones comprising mixtures of 
differentiated cells and other unidentified cells. In addition some clones appeared to be 
the products ofrestricted or committed progenitors. Similar results were obtained with 
in vivo lineage tracing. How might these results be explained in terms of the pattern of 
cell division and cell fate choices that are made? Two extreme views that remain 
consistent with these results can be imagined. On one hand, it may be that the earliest 
neural crest cells to emerge are totipotent for neural crest lineages at a given axial level, 
but that every cell division of that cell is a restrictive cell division. That is the products 
are more restricted in developmental potential than the progenitor. No progeny of a 
clone would possess the potency of the founder cell. (Although multi potent 
intermediate cell types that possess a proper subset of the developmental potential of the 
founder may be found.) Eventually, symmetrically dividing progenitors that have a 
finite capacity for cell division would be produced. Mitosis is a feature that may be 
controlled by environmentally derived signals. Ultimately those cells would 
differentiate and survive in the appropriate environment or simply die in an 
inappropriate environment. On the other hand, it may be that the totipotent neural crest 
cell is a self-renewing cell, that can produce committed progenitor cells when given the 
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appropriate intrinsic or environmentally derived signals. Under either mechanism the 
outcome is the same; a group of differentiated progeny develop from a single progenitor 
cell. The key difference between the two mechanisms is that in the later mechanism, a 
stem cell mechanism, the multipotent progenitor will self-renew. The property of self-
renewal can only be detected if individual progeny cells are assayed for the 
multi potency, i.e., sub-cloned to test whether they produce the same range of 
phenotypes as the original founder cell. There is a rich precedent for the existence of 
stem cells in certain mature vertebrate tissues, but a role in developmental systems is 
less clear. In the next section I will address this issue. 
Stem cells 
During the development of vertebrate organisms, a series of patterning events 
establish the major axes of the embryo and the germ layers (Spemann, 1938). The 
rudiments of the major organ systems are established through a series of interactions 
between the germ layer tissues. Within a developing organ, large numbers of relatively 
few cell types are produced. The mechanisms governing the production of mature cells 
within organs are generally unknown in detail, but for a few cases the pattern of cell 
proliferation and differentiation has been described (Hall and Watt, 1989; Potten and 
Loeffler, 1990; Ikuta et al., 1992). Two important features that emerge from analyses 
of progenitor cells in developing vertebrate organs are the diversity and size of the 
differentiated cell populations they generate. To produce sufficiently large numbers of 
differentiated progeny cells, many vertebrate progenitors have substantial proliferative 
capacity. The diversity of cell types generated from a single multipotential progenitor 
often reflects progressive mechanisms, in which progenitor cells gradually undergo 
changes in their developmental potential (Dexter et al., 1990). The identification and 
characterization of progenitor cells at different stages of development has been a major 
focus of research in cellular immunology. Similar work has been performed for skin 
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and intestine that, like the immune system, are required to replenish the differentiated 
cells throughout the life of the organism (Hall and Watt, 1989; Potten and Loeffler, 
1990). Such studies have led to the concept that progenitor cells may be divided into 
two broad categories: "blast" cells, or "transit amplifying" cells that are limited both in 
their proliferative capacity and in their developmental repertoire; and more 
developmentally-primitive "stem" cells that have an extensive capacity for self-
maintenance and are often (but not always) multi potent (Hall and Watt, 1989; Potten 
and Loeffler, 1990). While these studies concern with the maintenance of adult tissues, 
the "stem" cell and "blast" cell concepts may be useful when applied to developmental 
situations. 
The major task during organogenesis, that of producing a large number of a 
limited array of different cell types, is very similar to what is required in some adult 
tissues. There are situations encountered in the adult when an entire structure or 
complement of cells needs to be replaced, for example, during l:xme marrow 
transplantation or intestinal epithelial regeneration after irradiation. The regeneration of 
a structure has many similarities to the original formation of that structure, although the 
details may differ somewhat. Finally, the signaling systems and transcription 
machinery employed during the initial construction of the organ may be preserved and 
re-utilized in a regeneration or maintenance paradigm. 
For some tissues in the adult mammal there is an ongoing requirement for new 
cells. As stated above, a relatively simple example is the epithelium of the intestine 
(Potten and Loeffler, 1990). The cells of the intestinal epithelium are specialized 
transport cells that are exposed to topologically external surfaces of the animal and thus 
are keenly subject to abuse. These cells are constantly sloughed and replenished by 
stem cells that exist at the base of the intestinal villi. There are two basic properties that 
these stem cells exhibit. They renew themselves and they produce differentiated 
intestinal epithelial cells. They produce cells at a relatively constant rate. The intestinal 
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epithelial stem-cell has an enormous capacity for the production of differentiated 
progeny, but the range of cell types produced is small. For the development of most 
organs the progenitor is multipotent. A well studied example of a multipotent stem cell 
is the hematopoietic stem cell. 
All blood cells derive from one type of cell called the hematopoietic stem cell 
(HSC) (Spangrude et al., 1988; Ikuta, et al., 1992). The composition of blood, in 
terms of the relative proportion of cell types is fairly constant within an individual but 
can rapidly respond to requirements for specific cell types, such as lymphocytes and 
neutrophils when a pathogen infects the individual. Hematopoiesis is a process that 
begins in the embryo and continues throughout the life of the individual. In mice, 
HSCs can be detected in the embryonic yolk-sac, at a stage preceding major 
organogenesis. Later in development, HSC come to reside in the liver and ultimately in 
the bone-marrow of mature animals. The fetal HSC is capable of long-term 
repopulation of the blood of a lethally irradiated adults and in this sense gives rise to the 
adult form of the cell (lkuta et al., 1990; Jordan et al. , 1990). There are, however, 
some subtle differences that distinguish it from the adult HSC. For example, only 
fetal, but not adult, HSCs can produce vy3+ and Vy4+ T cells in the fetal thymic 
microenvironment (Ikuta, et al., 1992). In the example of hematopoiesis we find a 
situation wherein the initial development of the organ, blood, is mimicked by the 
maintenance process in the adult. A similar transition from an embryonic to an adult 
form of the progenitor may be found in the formation of the myelinating glia of the 
central nervous system (CNS). 
Oligodendrocytes, the myelinating glia of the CNS, can be generated by the 0-
2A progenitor, which can renew itself under certain conditions and can produce 
differentiated glia under other conditions (Raff et al., 1983). The extent of self renewal 
was at first thought to be limited to a few cell divisions after which 0-2A progenitors 
differentiated into oligodendrocytes. It was found, however, that under the control of 
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certain combinations of growth factors the 0-2A progenitor has an apparently unlimited 
capacity for self-renewal and at any point the progeny of an 0-2A progenitor can be 
forced to differentiate into one of two glial fates (Bogler et al., 1990). Further, it was 
found that the embryonic 0-2A progenitor could be caused to produce an adult form of 
the cell that persists in vivo through the life of the organism (Wren et al., 1992). The 
0-2A progenitor can also exhibit multipotency, at least in vitro, as it can be caused to 
differentiate to the GFAP expressing type-2 astrocyte phenotype by appropriate growth 
factor treatment. 
Recently multipotent progenitor cells capable of self-renewal have been isolated 
from the striatum of adult mouse (Reynolds and Weiss, 1992). Initially these cells 
express nestin, a marker that is characteristic of neuroepithelial progenitors cells 
(Lendahl et al., 1990). These cells can be induced in vitro to form astrocytes and 
neurons when attachment to a substrate is promoted. They will self-renew in 
suspension culture and are stimulated to divide by epidermal growth factor (EGF). 
These multipotent cells exist in the adult striatum as a relatively small percentage 
population. They also exhibit an extensive capacity for self-renewal under EGF 
stimulation. These cells are apparently stem cells for the striatum, but it is not clear 
what specific neuronal and glia potentials are available to them, nor is it is clear what 
role these cells play in the maintenance of adult brain tissue or in the regeneration of 
damaged regions. In a similar study, Cattaneo and McKay found that embryonic 
striatal neuron progenitors (nestin expressing cells) were stimulated to divide by 
fibroblast growth factor (FGF) and by nerve growth factor (NGF) in combination with 
FGF (Cattaneo and McKay, 1990). When the growth factors were withdrawn some of 
the cells underwent neuronal differentiation. A clonal culture of rat embryonic 
forebrain reveals that some cells are capable of producing both neurons and glia, but 
does not address the issue of self-maintenance (Temple, 1989). 
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Using the deficient retrovirus lineage tracing methodology described above, 
several groups report that a variety of cell types may arise from multi potent progenitors 
within the mammalian neocortex (Price and Thurlow, 1988; Walsh and Cepko, 1988; 
Walsh and Cepko, 1992). Further, they find that single progenitors can contribute 
neurons to several cortical layers. Some have termed these cells stem cells (Lendahl, et 
al., 1990), however, in none of these studies is self-renewal demonstrated. Further, 
these studies reveal only the fate of labeled cells and not the developmental potential of 
the progenitor. In the normal development of the mammalian neocortex, a laminar 
structure, the first neurons to be born populate the deepest layers starting with the 
cortical plate (for review see McConnell, 1991). Subsequent cell divisions produce 
neurons destined to populate more superficial layers. Neurons are all born in the 
ventricular zone and migrate toward the pial surface. In the ferret, neurons destined to 
populate the cortical plate and layer 6 are born at embryonic day 29 (E29). The neurons 
of the superficial layer 2/3 are born postnatally. Earlier work of McConnell suggested 
that the primary factor controlling the commitment of cortical neurons to a particular 
layer is the environment in which it goes through its final cell division (McConnell, 
1988; McConnell, 1989). Neurons born in E29 ventricular zone migrated to and took 
on traits characteristic of the deep layers even when they were transplanted to the 
postnatal ventricular zone. McConnell and Kaznowski have investigated the 
environmental control cortical neuron fate and its relation to the cell cycle (McConnell 
and Kaznowski, 1991). S-phase neuronal precursors are labeled with [3H]thymidine 
in the ventricular zone of E29 ferrets, then transplanted to neonatal brains after a time 
interval from 0 hours (i.e. , cells removed and labeled in vitro) to 24 hours (i.e., label 
injected into the donor brain and cells are allowed to be labeled for 24 hours before 
being transplanted). They find that cells that are allowed to undergo their last division 
in the donor ventricular zone (the 4, 8 and 24 hour timepoints) populate the deep layers 
when transplanted (donor behavior). By contrast, if the cells undergo their last division 
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in the host (the 0 hour timepoint), the labeled cells populate the superficial layers (host 
behavior). In addition, if they allowed the late transplants (i.e., 4, 8 and 24 hour 
timepoints) to develop for an additional round of cell division before analysis, then 
lightly labeled cells were found only to populate the superficial layers. They conclude 
that each progenitor is a dividing multipotent cell that responds to a changing 
environment. The results do not exclude an alternative hypothesis that the set of 
progenitors is heterogeneous with respect to developmental potential and that the 
differences observed are due simply to selective migration of labeled cells (van der 
Kooy, 1992). Indeed, McConnell and Kaznowski found that only 20% of the labeled 
cell migrated out of the injection site. They respond to the criticism by arguing that if a 
heterogeneous population of progenitors existed, the exact interval between labeling 
and transplantation would be irrelevant to the laminar fates of the progeny. They 
found, however, that the population of labeled cells behaved homogeneously, i.e., in 
the 0 hour transplant> 90% of the migrating cells populated to the superficial layers; in 
the 4 hour transplant> 90% of the migrating cells populated the deep layer; and the 
lightly labeled migrating cells always populated only the superficial layers. 
It seems reasonable to conclude that the precursor cells are multi potent cells 
responding to a changing environment. They may not be stem cells however. A 
progressive restriction model of development may apply. The transplants that have 
been done, however, take cells from a young animal and move them to an older animal. 
Hence, the multipotent cell would not necessarily undergo self-renewal, but instead 
could take on the more restricted state specified by the older environment. To address 
the possibility of self-renewal, one would have to label cells of the older animal, allow 
them to divide in the younger environment, and then test them for the ability to choose 
the deep layer fate. In such an experiment if the cells choose the deep layer fate then the 
precursor probably undergo self-renewal. If they choose the superficial fate, however, 
they have become restricted. 
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Do neural crest derivatives develop via a stem cell mechanism? 
If neural crest-derived tissues develop by way of a stem cell mode there are 
several properties that the neural crest cells will exhibit. The first property is 
multipotency. While multipotency is not a property of all stem cell systems, it is a 
property of many and would be expected for neural crest cells given the range of 
derivatives that arise from the neural crest. The second property, which may be the 
most defming property of stem cells, is self-renewal. Strictly speaking, self-renewal 
refers to the ability of a given stem cell to replace itself at every cell division. Self-
renewal may arise through either symmetric or asymmetric cell divisions. An 
asymmetric cell division being one in which one daughter of the pair is a relatively 
restricted cell, i.e., a cell whose developmental potential is less than the parent, and the 
other daughter is, like the parent, a stem cell. A third important property of stem cells 
is the ability to produce differentiated progeny either by way of a blast cell population 
or by direct conversion. 
To study the problem at this level, it is necessary to determine the fates of single 
progenitors either in situ or in novel environments where latent potentials may be 
revealed. As discussed earlier, in situ clonal analysis of pre-migratory and migrating 
neural crest cells has been done (Bronner-Fraser and Fraser, 1988; Bronner-Fraser and 
Fraser, 1989; Frank and Sanes, 1991). These studies suggest that single pre-migratory 
neural crest cells are multi potent and capable of forming all of the derivatives available 
to the trunk neural crest. Earlier the two extreme models of neural crest development 
were discussed. It is important to distinguish between these two models because it 
affects the way one thinks about the normal development of neural crest-derived 
structures. If self-renewing multi potent neural crest cells are present in a developing 
structure the choices made by the precursor cells would very different from the choices 
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that would be made by cells already committed to particular differentiated fates. For 
example, consider the development of a sensory ganglion. The ganglion contains two 
cell types, neurons and glia. If the stem cell model were true, then the choices made by 
a stem cell in the ganglion would be to produce a neuron or to produce a glial cell. In 
addition the stem cell may choose to self-renew. If, however, the restrictive model 
were true, committed progenitors of many lineages would form, then either they cells 
would migrate in a directed fashion to their appropriate location or a mixture of 
committed progenitors would populate the ganglion. Once in the ganglion the choices 
available to those cells would be to survive and divide, if they were neuronal or glial 
progenitors; or to die, if they were progenitors of any other cell type. 
In order to determine the developmental potential of mammalian neural crest 
cells and further to distinguish between the two models of neural crest development I 
developed a system in which rat neural crest cells can be grown in clonal culture. 
These investigations are detailed in chapter 2. 
Environmental control of neural crest cell lineage specification 
Mapping of neural crest developmental potential 
The first evidence that the fate of neural crest cells may be controlled by the 
embryonic environment in which they develop came from studies designed to test the 
developmental potential of neural crest derived from different axial levels. Using the 
chick-quail marker system, Le Douarin and her colleagues found that the neural crest of 
any given axial level possesses a larger developmental potential than is normally 
realized (Le Douarin, 1980; Le Douarin, 1982). Regions of the neural crest that do not 
normally produce a given cell type possess the capacity to do so when challenged with 
the appropriate environment. Here are examples of transplantation studies that reveal 
the environmental effect on neural crest cell fate: 
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The axial level corresponding to sornites 18-24 in the chick is the only part of 
the neural crest that normally produces adrenal chromaffin cells. However, when 
neural crest from any other axial level is transplanted to that region, adrenal chromaffin 
cells arise from the transplanted tissues (Le Douarin and Teillet, 1974). Hence, while 
every level of neural crest tested possesses the ability to form chromaffin cells, only 
neural crest from the level of sornites 18-24 actually does. It is at that level of the 
organism that the adrenal gland forms and, as will be discussed later, the environment 
of the adrenal gland directs the formation of chromaffin cells (Anderson, 1993). 
The trunk of the neural crest does not normally generate ectomesenchymal 
derivatives. In a study of Nakamura and Ayer-Le Lievre, however, when 
adrenomedullary neural crest of quail was transplanted to the level of the 
rhombencepahlon in host chick embryos, the transplanted neural crest differentiated 
into mesectodermal derivatives, including connective cells in the walls of blood vessels 
and dermis of the neck (Nakamura and Ayer-Le Lievre, 1982). The quail cells, 
however, were not found to form cartilage or bone . Thus the truncal crest, which 
never contributes ectomesenchyme can be caused or allowed to do so in the 
environment of the rhombencephalon. 
The fact that cartilage and bone do not form from truncal neural crest indicates 
that profound differences in developmental potential may exist between different axial 
levels of the neural crest. Within the cephalic crest there may exist differences in 
developmental potential at different axial levels. There are certainly differences in the 
expression of homeobox containing genes that may be in part responsible for the axial 
level-specific structural differences found during craniofacial development (Noden, 
1991). The mesencephalic neural crest expresses an engrailed homolog before and 
during its migration, whereas adjacent regions of the neural crest apparently do not 
(Gardner et al., 1988; Gardner and Barald, 1991). There are indications that the vagal 
neural crest, which normally will produce enteric ganglia, is more invasive than trunk 
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neural crest. Vagal neural crest, when transplanted to the level of adrenomedullary 
neural crest, will invade the gut and form much of the enteric ganglia posterior to that 
axial level (Le Douarin and Teillet, 1974). Adrenomedullary neural crest can not 
normally invade the gut, but when it is transplanted to the vagal level is capable of 
populating the pre-umbilical gut and forming enteric ganglia (Le Douarin and Teillet, 
1974; Le Douarin et al., 1975). The differences in developmental potential that exist 
between axial levels of the neural crest are important to note and may reflect intrinsic 
differences between classes of neural crest cells. Those differences may be crucial for 
the normal formation of complex structure in the head and neck. Much of the 
developmental potential of different axial levels, however, is overlapping and similar 
mechanisms of control over the generation of differentiated fates may operate even 
though the range of possible fates may vary somewhat. 
Undetermined neural crest cells can be found in developing neural crest-derived 
structures 
When tissue is transplanted from a neural crest derivative structure of a donor 
embryo to the neural crest of a younger host embryo, it has been found that often the 
donor tissue possesses a developmental potential greater than would be normally 
realized in the source tissue. In a series of experiments carried out by Le Douarin and 
her co-workers, pieces of E4.5 to E6 quail sympathetic and dorsal root ganglia were 
back-transplanted into neural crest migration pathway at the adrenomedullary level of 2-
day old chick embryos (Le Lievre et al., 1980). Sympathetic ganglion grafts were 
found to contribute neurons and satellite cells to the sympathetic ganglia, chromaffin 
cells to the adrenomedullary cords and Schwann cells to the ventral roots, but did not 
contribute neurons to DRGs. On the other hand, grafted DRGs were found to 
contribute the same array of cells as the sympathetic ganglia, but, in addition, were able 
to contribute neurons to the DRGs. For the most part DRGs do not express adrenergic 
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traits. Price and Mudge reported, however, that in 3-4 week old rats, some DRGs 
contained a small number of tyrosine hydroxylase (TH) expressing neurons. They 
found that the DRGs never expressed dopamine-!3-hydroxylase (Dl3H), nor were TH 
expressing cells ever found in embryonic or perinatal DRGs of rats or chickens (Price 
and Mudge, 1983). This observation is supported by Katz in his studies of cranial 
sensory ganglia, such as the petrosal ganglion, where there are many adrenergic cells. 
He found that the neural crest derived neurons express TH only transiently, whereas 
TH is stably expressed by placode derived neurons. In addition, he does not find 
adrenergic neurons in embryonic or perinatal DRGs (Katz, 1991 ). Mercer et al., using 
a Dl3H promoter to drive !3-galactosidase expression in transgenic mice found at most 2 
!3-galactosidase expressing cells in any DRG (Mercer et al., 1991). Hence, even 
though adrenergic properties are rarely expressed in the DRG, and never expressed in 
the embryonic DRG, the developing ganglion possesses the capacity to produce 
sympathetic neurons and chromaffin cells. Similarly, Ciment et al., found that early 
DRGs, from embryos up to 5 days old, possess the capacity to produce melanocytes 
even though melanocytes are never found in the DRG (Ciment et al., 1986). These 
examples point up the fact that although certain phenotypes are never manifest in a 
given derivative structure the potential for their formation exists. 
These transplantation studies provide suggestive evidence that the environment 
serves to control cell fate decisions in the development of neural crest derived 
structures. By transplantation to a novel environment, one can test the developmental 
potential of a given tissue. (Although the total developmental potential of a transplanted 
tissue will not necessarily be revealed, specific developmental potentials can be tested.) 
In addition, the fact that a lineage decision has been made can be measured. That is, 
transplantation studies show that a choice between lineages, e.g., sympathetic neuron 
vs. sensory neuron, can be made by cells within the transplanted tissue. The problem 
is that transplantation studies cannot show what the nature of the decision is. For 
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example, one cannot distinguish between the induction of a novel phenotype from an 
undifferentiated progenitor, and the selective growth (or selective loss) and 
differentiation of pre-committed progenitors. This type of ambiguity is primarily due to 
the fact that in these transplant studies only populations of cells are examined, and 
selection can always explain the outcome of the experiment. 
Sympathoadrenallineage 
As stated above, the sympathoadrenal (SA) lineage comprises the neurons of 
the sympathetic ganglia and the chromaffin cells of the adrenal medulla. These two cell 
types share several characteristics, perhaps most importantly they are both adrenergic 
cells and thus express a common neurotransmitter biosynthetic pathway. The two 
cells, however, have dramatically different morphologies and serve different 
physiological roles for the organism. Although both cell types synthesize 
catecholarnines, most chromaffin cells express an additional enzyme, 
phenylethanolamine-N-methyl transferase (PNMT), whose function is to convert 
norepinepherine to epinepherine. The environment in which these cells develops 
appears to control the differences between them (for review see Anderson, 1993). The 
adrenal gland produces large amounts of glucocorticoid steroid hormone (Roos, 1967). 
The glucocorticoids appear to affect the development of chromaffin cells from SA 
progenitors in two ways. Initially, glucocorticoids can inhibit the neuronal 
differentiation of embryonic SA progenitors taken from E14.5 rat adrenal glands. 
Later, glucocorticoids promote the maturation of chromaffin cells, as marked by the 
induced expression of PNMT (Michelsohn and Anderson, 1992). On the other hand 
adrenal SA progenitors can undergo neuronal differentiation in the absence of 
glucocorticoids (Anderson and Axel, 1986). SA progenitors derived from developing 
sympathetic ganglia appear to behave in the same way (Carnahan and Patterson, 1991). 
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Several investigations reveal that NGF can function to elicit the conversion of 
chromaffin cells into sympathetic neurons (Unsicker et al., 1978; Doupe et al., 1985a; 
Doupe et al. , 1985b). This result suggests that NGF may serve a similar function in 
the normal development of sympathetic neurons. At the time of neuronal 
differentiation, however, there is no NGF present in the sympathetic ganglia (Davies et 
al., 1987; Korsching and Thoenen, 1988). This suggests that perhaps some other 
factor or factors act in the sympathetic ganglion to promote neuronal differentiation. 
The rat pheochromocytoma line PC12, has been useful for investigations into the roles 
of specific factors in neuronal differentiation (Greene and Tischler, 1976). PC12 cells 
have been found to undergo neuronal differentiation in response to NGF (Greene and 
Tischler, 1976). Several reports indicate that both basic and acidic FGF can mimic 
NGF and act to induce neuronal differentiation in PC12 cells (Togari et al., 1985; 
Wagner and D'Amore, 1986; Rydel and Greene, 1987; Schubert et al., 1987). Given 
the fact that PC12 cells derive from a mature rat chromaffin cell it is reasonable to 
expect that FGF may also act to induce neuronal differentiation of primary adrenal 
chromaffin cells. Chapter 3 details investigations into this possibility. 
The sympathoadrenallineage includes also another neuronal phenotype. 
Patterson and his colleagues found that when cultures of sympathetic neurons were 
grown in the presence of medium conditioned by embryonic heart cells, the neurons 
change their neurotransmitter phenotype. Specifically, they down-regulate the 
production of catecholamines and begin to produce acetylcholine (Patterson and Chun, 
1977; Fukada, 1985) (for reviews see Patterson, 1978; and Patterson, 1990). This 
activity may be important in the ultimate specification of sympathetic neuron phenotype 
and has been demonstrated to occur in vivo (Schotzinger and Landis, 1988; 
Schotzinger and Landis, 1990). The factor responsible for the activity, as derived from 
embryonic heart cells, was recently found to be leukemia inhibitory factor (LIF) 
(Yamamori et al. , 1989). In addition, postmitotic neurons can undergo further 
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phenotypic diversification with respect to the neuropeptide expression (Nawa and 
Patterson, 1990). This effect is modulated by specific non-LIF components of the 
heart cell conditioned medium. Thus we see in the sympathoadrenallineage that not 
only do environmental factors affect cell fate choices in dividing progenitors, but the 
environment can re-specify or modulate the ultimate phenotype of post-mitotic 
sympathetic neurons. 
The sympathoadrenallineage provides a system with fairly well defined 
progenitors and products that permits detailed investigations into the role of specific 
factors in cell fate choice. It would be of interest, however, to be able to describe the 
relationship between the earliest neural crest cells and a specific lineage, like the SA 
lineage, in terms of the intermediate cell types and the factors required to make the 
transitions between them. The first step toward this goal, as outlined above is to 
determine the developmental potential of the earliest neural crest cells and to establish a 
culture system in which specific environmental factors can be tested. Some 
investigations into the developmental potential of early neural crest cells are described in 
chapter 2. Some of the problems associated with attempts to address the role of 
specific environmental factors are discussed in the next section. 
Primary culture of early neural crest cells 
Most of the work concerning the effect of environment on neural crest cell 
differentiation has been performed with large populations of primary neural crest cells, 
either in primary explants of migrating neural crest cells or in aggregates of neural crest 
cells formed when neural tubes are cultured on a non-adhesive substrate. The results of 
such experiments are difficult to interpret for several reasons. First, in such an 
experiment it is difficult to distinguish inductive, mitogenic and trophic activities. 
Second, there is reason to believe the target population is heterogeneous. For example, 
in quail primary neural crest cultures, the neural crest cells are heterogeneous with 
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respect to expression of both the HNK-1 and R24 epitopes (Maxwell et al., 1988). 
Barald fmds that mesencephalic neural crest cells are heterogeneous with respect to their 
expression of a choline uptake mechanism antigen (Barald, 1988). Further, this 
heterogeneity may reflect some commitment to cholinergic differentiation (Barald, 
1989). Barbu et al., have described heterogeneity in migrating neural crest cell 
expression of the antigen recognized by the monoclonal antibody G 1 N1 (Barbu et al., 
1986). Primary, neural crest cells of rat are heterogeneous in their expression of low-
affinity nerve growth factor receptor (LNGFR) (Smith-Thomas and Fawcett, 1989; 
Smith-Thomas et al., 1990). In addition, the Long-Evans strain of rat is heterogeneous 
for HNK-1 epitope expression (Erickson et al., 1989). Nonetheless, studies of mass 
cultures of neural crest may be useful for providing a relatively easy culture system to 
screen factors for activities that affect a large percentage of the neural crest cells. 
Murphy et al., found that LIF can promote the formation of sensory neurons in cultures 
of mouse neural crest (Murphy et al., 1991). Forbes and Maxwell found enhanced 
adrenergic differentiation in the presence of EHS sarcoma extracellular matrix material 
(Maxwell and Forbes, 1990). Morrison-Graham and Weston found that skin cells 
promote pigment cell formation in cultures of mouse neural crest (Morrison-Graham et 
al., 1990). Kalcheim et al., found that FGF in solution promotes the survival of non-
neuronal cells in primary neural crest cultures and can promote neuronal differentiation 
when presented by FGF expressing cells (Kalcheim, 1989; Brill et al., 1992). In 
addition Kalcheim reported that neurontrophin-3 (NT-3) is a mitogen for primary avian 
neural crest cells (Kalcheim et al., 1992). Finally, Erickson and Turley, found that 
epidermal growth factor (EGF) is a mitogen for neural crest cells and can also serve to 
regulate the production of extracellular matrix molecules, hyaluronic acid, chondroitin 
sulfate proteoglycan, and cell-surface heparin sulfate proteoglycan (Erickson and 
Turley, 1987). 
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Clusters of neural crest cells isolated from neural tubes cultured on a non-
adhesive substrate lend some insight into another type of environmental factor. Vogel 
and Weston picked neural crest cell clusters at various times after formation, dispersed 
them and cultured them (Vogel and Weston, 1988). The crest cells taken from early 
clusters, 18-24 hours old contained a majority of cell that expressed a ganglioside 
antigen recognized by the antibody A2B5. These cell produced many neurons in the 
dispersed cultures and relatively few melanocyte. On the other hand, if the clusters 
were left aggregated for an additional 24 hours, with or without the neural tube present, 
neural crest cells were found to no longer express the ganglioside and differentiated into 
melanocyte rather than neurons. There are several possibilities to explain these results. 
There might be distinct populations of neuroblasts and melanoblasts within the cluster 
and the cluster environment is not supportive of the neuroblasts and favors the 
proliferation of melanoblasts. Another possibility is that the cluster is comprised of 
stem cells and derivatives and that the cluster environment favors the production of 
melanoblasts over neuroblasts. Or, the cluster environment does not allow 
differentiation to occur but dispersal does. Further, over time the stem cells lose 
neurogenic potential, so that when the cells are dispersed they differentiate. If they are 
dispersed early they differentiate into neurons, and if they are dispersed late they 
differentiate into melanocytes. These possibilities are cannot be distinguished when 
populations of cells are examined. To resolve the issue one needs to analyze the 
behavior of single cells. If single cells were marked in 18 hour clusters, one could test 
whether the progeny of those marked cells (some fraction of which will produce 
neurons when dispersed at 24 hours and some fraction of which will produce 
melanocytes when dispersed at 48 hours) are supported by the cluster environment. 
That is, does the cluster environment select against neuroblasts or does it convert 
would-be neuroblasts into melanoblasts. The clusters provide an example of an 
environmental effect that may be mediated by cell-cell contact and not soluble factors. 
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Without a clonal analysis of their development, however, it is impossible to resolve 
what the primary activity of the cluster environment is. 
There are some published examples of environmental effects on cell fate choices 
in clones of neural crest cells. Satoh and Ide found that application of aMSH to clonal 
cultures of quail neural crest had the effect of increasing the number of clones 
producing pigment cells (Satoh and Ide, 1987). Sieber-Blum and Cohen showed that 
when clones of quail neural crest cells are grown on a extracellular matrix extract that 
both the number of adrenergic clones and the number of adrenergic cells within each 
clone is increased (Sieber-Blum and Cohen, 1980). In a recent study Sieber-Blum 
shows that the number of SSEA-1 expressing cells within quail neural crest clones is 
increased when the clones are grown with BDNF (Sieber-Blum, 1991). Kalcheim et 
al., had previously shown that BDNF could stimulate neuronal differentiation and 
survival in mass cultures of avian neural crest cells (Kalcheim and Gendreau, 1988). 
In these studies it is clear that the environmental factor has some effect. It is difficult, 
however, to distinguish between inductive, trophic or mitogenic activities acting either 
on the clone founders themselves or on specific progeny cell types. 
As discussed above, transplantation studies indicate that the environment can 
affect the choices of fate made by populations of cells. In vivo clonal analyses indicate 
that many primary neural crest cells are multipotent. In vitro clonal analyses indicate 
that many neural crest cells are multipotent, and may be controlled by environmental 
factors to express specific differentiated phenotypes. There are important details 
concerning the development of neural crest derivative that remain to be addressed. 
What are the intermediate cell types that form in the transition from multipotent 
(totipotent) stem cells to the ultimate derivative cell types? For example, Baroffio et al., 
observed several types of clones that contained sub-sets of the possible derivatives 
(Baroffio, et al., 1988). Were such clones founded by relatively restricted, multipotent 
but not totipotent intermediate cell types that were the progeny of a stem cell? Are there 
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unique stem cell types generated at different axial levels? The apparent lack of a 
mesectodermal developmental potential among trunk neural crest cells, and the 
multi potency of cephalic neural crest suggest that there are at least two distinct stem cell 
types. What are the factors that actually control cell fate decisions? And how do those 
factors act in tissues where distinct cell types, in close contact, derive from the same 
progenitor? The answers to these questions will lend important insight into problems 
such as gangliogenesis, where the production of several distinct cell types all arising 
from the same cell are tightly controlled to produce the mature structure. 
In this review, I have outlined some of the problems of neural crest cell 
biology. The work to be presented will speak to two problems. First, how do neural 
crest cells achieve the observed diversity of lineage specification in terms properties of 
precursor cells and their immediate progeny? The work presented in chapter 2, 
concerning the identification and characterization of a primary neural crest stem cell, 
addresses a question that distinguishes between the extreme models of neural crest 
development I have presented. That is, do the earliest multi potent neural crest cells 
undergo self-renewal, in addition to the production of differentiated progeny? In other 
word are they stem cells or do they develop by way of continual restriction? The 
second question is: how does the environment exert its influence over cell fate choices? 
Chapter 2 describes the effect of an environmental factor on the fate of neural crest cell 
clones. In addition, chapter 3 describes the activity of basic FGF on chromaffin cells. 
Finally, Chapter 4 presents evidence that an antibody originally thought to be a 
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CHAPTER 2: Isolation and characterization of self-renewing, 
multipotent mammalian neural crest cells 
43 
Abstract 
Clonal and lineage analysis of avian neural crest cells has revealed that many of 
these cells are multipotent. However, it is not clear whether the immediate progeny of 
these cells are collllllitted to distinct sublineages or whether these progeny are 
themselves multi potent, as would occur in a stem cell lineage. To address this issue we 
have isolated mammalian neural crest cells using a cell surface monoclonal antibody, 
and examined their developmental potential in culture. These neural crest cells are both 
multipotent, and able to generate clonal progeny that retain such multipotency. 
Moreover, the composition of the substrate can determine whether these cells 
differentiate into both neurons and glia, or just glia. These data provide the first 
evidence that early neural crest cells have stem cell properties, and establish a system in 
which the roles of environment and lineage restriction in crest development may be 
investigated at the single cell level. 
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Introduction 
The vertebrate nervous system contains a very large number of different cell 
types, but the cellular and molecular mechanisms that generate this diversity during 
development are largely unknown. Lineage tracing studies performed in vivo using 
retroviral genomic markers or injected tracer dyes have revealed that many neural 
progenitor cells are multi potent; i.e., they give rise to more than one cell type, including 
in many cases both neurons and glia (for reviews, see Sanes, 1989; McConnell, 1991). 
While such studies define the fates of individual progenitor cells in the embryo, they do 
not necessarily reveal the developmental potentials of these cells, or how these 
potentials change with time. The development of the hematopoietic system, for 
example, involves progressive restrictions in the developmental capacities of progenitor 
cells (for review, see Metcalf, 1989). The isolation and characterization of different 
populations of hematopoietic progenitor cells has been a major focus of research in 
cellular immunology (Spangrude et al., 1988; Ikuta, et. al., 1992). By contrast, few 
neurogenic progenitor cell populations have been similarly studied. 
Experimental analysis of purified progenitor cell populations isolated from the 
developing nervous system has been carried out in the optic nerve-derived 02A lineage 
(for review, see Raff, 1989) and the neural crest-derived sympathoadrenal (SA) lineage 
(for reviews, see Patterson, 1990; Anderson, 1993). In both of these cases, isolated 
progenitor cells placed in culture have been shown to have at least two potential fates, 
the choice among which is controlled by an interplay between instructive environmental 
signals and intrinsic developmental programming. These progenitors, however, appear 
to have a limited repertoire of cell fates and derive from relatively late stages in neural 
cell lineage diversification. Far less is known about the properties of the early 
neuroepithelial cells that function in the initial stages of neurogenesis (McKay, 1989; 
McConnell, 1991 ). Although progenitor cells from such early stages are often referred 
to as "stem" cells (e.g., see Cattaneo and McKay, 1990) the experimental criteria used 
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to define stem cells in other systems (Potten and Loeffler, 1990) have not been 
rigorously applied. These properties include the ability to self-renew, divide 
asymmetrically and generate differentiated progeny. In addition, many (but not all) 
stem cells are multipotent (Hall and Watt, 1989). 
The neural crest has provided a system for the study of neural cell type 
diversification that is simpler and experimentally more accessible than the CNS. Neural 
crest cells disperse from the dorsal margin of the neural tube and undergo extensive 
migrations before differentiating to generate the neurons and glia of the peripheral 
nervous system (LeDouarin, 1982). Classical experiments in avian embryos have 
revealed that the fate of transplanted neural crest cell populations can be strongly 
influenced by their environment (LeDouarin, 1980). Clonal analysis of avian neural 
crest cells has been carried out both in vitro and in vivo, and has revealed that many 
(but not all) early neural crest cells can generate the full range of crest derivatives in the 
trunk and mesencephalic regions (Sieber-Blum and Cohen, 1980; Baroffio et al., 1988; 
Bronner-Fraser and Fraser, 1989; Frank and Sanes, 1991). Taken together, these data 
are consistent with the idea that the environment acts to control the choice of fate by 
multipotent neural crest cells. 
Arguing against this simple view, however, are data revealing cellular 
heterogeneity in the neural crest. For example, some neural crest cell clones contain 
only a single derivative, such as Schwann cells (Bronner-Fraser and Fraser, 1989; 
Dupin et al., 1990; Frank and Sanes, 1991 ). A subpopulation of mesencephalic neural 
crest cells isolated using a cholinergic surface marker appears restricted to a 
parasympathetic neuronal lineage (Barald, 1988; Barald, 1989). Furthermore, neural 
crest cell populations with partially-restricted developmental capacities have been 
identified both in vivo (Artinger and Bronner-Fraser, 1992) and in vitro (Vogel and 
Weston, 1988). To reconcile these observations with the existence of multipotent cells, 
it has been proposed that neural crest cell lineage diversification may occur by a process 
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analagous to hematopoiesis (Dexter et al., 1990), in which multi potent neural crest cells 
give rise to their differentiated progeny via the production of "blast," or "transit 
amplifying" cells, which are limited both in their proliferative capacity and in their 
developmental repertoire (Anderson, 1989; Sieber-Blum, 1990; LeDouarin et al., 
1991). Environmental factors could then influence the choice of fate by multiopotent 
cells and/or the survival of specific progenitor subpopulations. 
An important question raised by such a model is whether multi potent neural 
crest cells generate immediate progeny that are already developmentally restricted, or 
whether such multipotent cells undergo at least limited self-renewal analagous to stem 
cells in other lineages. To address this question, we have isolated mammalian neural 
crest cells using a cell-surface monoclonal antibody and examined their properties in 
clonal culture. We show that these cells are not only multipotent, but that such 
multipotent cells are capable of self-renewal. Moreover, the fate of these multipotent 
cells, and not simply their attachment or survival, can be controlled by both their culture 
medium and the composition of their substrate. With time in culture, some 
developmentally-restricted progeny cells appear to be generated. These data provide 
evidence for a hematopoietic-like mechanism of neural crest cell lineage diversification, 
and establish a system in which the molecular control of this diversification process can 
be further investigated. 
Results 
Isolation and cloning of multipotent rat neural crest cells 
We have chosen to isolate mammalian neural crest cells from rat rather than 
mouse embryos for two reasons. First, we wish ultimately to relate the developmental 
properties of these cells to those of neural crest-derived sympathoadrenal progenitors, 
which we have previously characterized in the rat using a series of antibody markers, 
many of which are rat -specific (Anderson and Axel, 1986; Anderson et al., 1991; 
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Michelsohn and Anderson, 1992). Second, cell-surface antibody markers were 
available that react with rat (Smith-Thomas and Fawcett, 1989) but not mouse neural 
crest cells. These antibodies recognize the mammalian low-affinity NGF receptor 
(LNGFR) (Chandler et al., 1984; Stemple and Anderson, 1990). 
When E10.5 neural tubes are cultured on a fibronectin (FN) substrate, most of 
the neural crest cells that emigrate from the neural tubes over a 24 hour period (Fig. lA) 
express LNGFR, as recognized by the monoclonal antibodies 217c (not shown) and 
192IgG (Figure lB, yellow/green fluorescence). Flow cytometry of 24 hour neural 
crest explants indicates that > 50% of the neural crest cells are moderately to strongly 
LNGFR+ (Figure lD). All of the neural crest cells also express nestin (Fig. 1B, 
red/orange fluorescence), an intermediate filament protein found in immature 
neuroepithelial cells (Rockfield and McKay, 1985) and in Schwann cells (Friedman et 
al., 1990). Double-label immunofluorescence staining at clonal density confirmed the 
co-expression of LNGFR and nestin by individual neural crest cells (Figs. lB, 2A-C). 
We established conditions that permitted the growth in low-density culture of 
LNGFR + cells that had emigrated from the neural tube in vitro. In basal L-15 C02 
medium (Hawrot and Patterson, 1979), the combination of fetal bovine serum (FBS) 
and chick embryo extract (CEE) allowed the survival and growth of neural crest 
colonies (data not shown). Under these conditions, however, the neural crest cell 
clones soon lost LNGFR expression, and subsequent differentiation of neuronal or 
glial cells was not observed. Since our empirical observations indicate that the ability to 
differentiate to neurons and glia correlates with the maintenance of early LNGFR 
expression, we developed a chemically defined medium (see Experimental Procedures) 
that would permit neural crest cell survival and maintain LNGFR expression. While 
this medium was sufficient for cell survival at high plating densities it was not able to 
support colony growth at clonal densities. If the defined medium was supplemented 
with 10% FBS, colonies were able to grow at clonal density, but LNGFR expression 
48 
Figure 1. Neural crest outgrowth from rat E10.5 neural tube at 24 hours in culture. 
A neural tube that had been growing for 24 hours in culture is shown in panel 
A. The upper third of the micrograph contains the neural crest cell outgrowth from the 
dorsal side of the explanted neural tube. The neural crest cells are in a dispersed 
monolayer and the neural tube retains a multilayered epithelial structure. In panel B is 
shown, at higher magnification, a region of neural crest cells after fixation and 
immunocytochemical staining with a monoclonal antibody to nestin (in red) and a rabbit 
antiserum to LNGFR (in green). (C) Neural crest cells were labelled with monoclonal 
anti-LNGFR 192IgG and sorted by a fluorescence activated cell sorter (FACS). A 
control profile from the FACS shows the background staining for the fluorescent 
secondary antibody (C). Panel D shows the FACS profile from anti-LNGFR stained 
cells. Greater than 70% of the neural crest cells show some LNGFR immunoreactivity, 
-25% expressed high levels and were collected for subsequent analysis. The log of 
fluorescence intensity is plotted on the abscissa. The cell number is represented in the 
plot by the density of the pixels The scale of pixel densities is displayed in the inset. 
The cell size, as reported by the foward angle light scatter, is plotted on the ordinate. 
The scale bar in panel B corresponds to a length of 50 J..lm for panel B and to 500 J..lm 
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Figure 2. Clonal expansion ofLNGFR+, nestin+ rat neural crest cells. 
(A, B, C) a single neural crest founder cell fixed, stained and photographed 24 
hours after plating at clonal density. (D, E, F) a clone derived from a similar single 
founder cell after 3 days in culture. (A, D) phase contrast micrographs. Double-label 
immunofluorescence was performed with rabbit antiserum to LNGFR (B, E) and 
monoclonal anti-nestin (C, F). Both founder cell and the cells in the clone co-express 
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was lost (not shown). When the defined medium was supplemented with 10% CEE 
rather than FBS, however, the neural crest cells survived, proliferated at clonal density 
and continued to express LNGFR and nestin for several cell generations (Figure 2E,F). 
We term such medium standard medium (SM). 
In order to assess the developmental potential of individual neural crest cells, it 
was necessary to establish that the colonies that developed in low density cultures were 
actually clones. Neural crest cells taken from 24 hour neural tube explants were plated 
at a density of ~225 cells I 100 mm dish. After the cells attached, individual LNGFR+ 
neural crest cells were identified and inscribed with a ~3 mm circle drawn on the bottom 
of the dish. The circles were generally large enough to permit the unambiguous 
identification of the progeny of the cell at any time during the experiment. When such 
single, identified LNGFR+ neural crest cells were grown in SM for 9-14 days, they 
generated large clones that contained both cells with a neuronal morphology (Figure 3C 
arrow), as well as non-neuronal cells. Quantification indicated that >60% of the clones 
contained such neuronal cells (see Fig. lOB). These neuronal cells no longer expressed 
LNGFR and nestin (Fig. 3D). However, they could be triply-labeled by monoclonal 
antibodies to pan-neuronal markers such as neurofilament (Fig. 4E) and high-polysialic 
acid (PSA) NCAM (monoclonal antibody 5A5; Fig. 4D), as well as by a polyclonal 
antibody to peripherin (Fig. 4F), an intermediate filament protein preferentially 
expressed by peripheral neurons (Portier et al., 1984; Parysek et al., 1988; Parysek 
and Goldman, 1988). 
The neuron-containing clones also contained non-neuronal cells (Fig. 3A,C). 
These cells continued to express LNGFR and nestin (Fig. 3B) and displayed an 
elongated Schwann cell-like morphology (Brockes and Raff, 1979). While immature 
Schwann cells are known to express both LNGFR and nestin (Friedman et al., 1990; 
Jessen et al., 1990), these markers are insufficient to identify Schwann cells in this 
system since they are expressed by the neural crest cell precursor as well. Other 
53 
Figure 3. LNGFR and nestin expression in a neuron containing clone. 
Two separate fields from a single clone are shown. As in Figure 2, the clone 
has been double labeled with rabbit antiserum to LNGFR (green fluorescence) and 
monoclonal anti-nestin (orange fluorescence). Panels A and B show a field containing 
LNGFR+, nestin+ cells with a Schwann cell-like morphology. Panels C and D show 
another region containing neurons which express neither LNGFR nor nestin. The scale 
bar in panel D corresponds to a length of 50 11m. 
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Figure 4. Expression of neuronal traits in clones of LNGFR+ founders. 
A single founder cell (A, B) and its resulting clone (C-F) after 10 days growth 
are shown. Phase contrast micrographs of the founder (A) and the clone (C) are 
shown. The coresponding fluorescence micrographs depict the LNGFR expression of 
the founder (B) and the expression of several neuronal markers in the clone. Triple 
labeling with mouse IgM anti-NCAM (D), mouse IgG anti-NF160 (E), and rabbit anti-
peripherin (F) reveals the coincidence of these markers in a subset of the cells in the 
clone. The scale bar in panel F corresponds to a length of 50 1-1m. 
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Schwann cell markers, such as glial fibrillary acidic protein (GFAP) (Jessen et al., 
1990), and the sulfatide antigen recognized by antibody 04 (Mirsky et al., 1990) were 
not expressed by these LNGFR+ cells (not shown). We therefore sought to promote 
Schwann cell differentiation by transferring the clones into a medium known to 
maintain differentiation of postnatal Schwann cells isolated from peripheral nerve 
(Mirsky et al., 1990). This medium consisted of SM with the addition of both 10% 
FBS and 5 11M forskolin, an activator of adenylate cyclase. 
Following 5-10 days in such Schwann cell differentiation (SCD) medium, most 
of the non-neuronal cells in the clones expressed GFAP (Figure 5E), the sulfatide 04 
antigen (Fig. 5B), and the peripheral myelin protein Po (Fig. 5C,F). Although GFAP 
is expressed by astrocytes and 04 by oligodendrocytes in the CNS, the co-expression 
of these two markers in the same cell is unique to peripheral glial cells (Jessen et al., 
1990; Mirsky et al., 1990; Morgan et al., 1991). Moreover, Po is uniquely expressed 
by myelinating peripheral glia (Lemke, 1988). These data therefore indicate that the 
LNGFR+, nestin+ neural crest cells are able to differentiate into Schwann cells, under 
appropriate culture conditions. 
The addition of serum and forskolin at this late stage of culture did not appear to 
be toxic to neurons that had differentiated prior to transfer into SCD medium (Fig. 6). 
In fact the number of neurons appeared to increase after such medium transfer (not 
shown). Triple-label immunofluorescence staining using rabbit polyclonal anti-
peripherin, mouse monoclonal lgM 04, and mouse monoclonal IgG anti-GFAP 
revealed that sulfatide+ and GFAP+ Schwann cells were present in the same clones as 
peripherin+ neurons (Fig. 6C,D). 
Primary neural crest clones containing identifiable neurons and glia usually also 
contained a small number of cells, that displayed a flattened, undifferentiated 
morphology. These cells did not express any of the neuronal or glial lineage markers 
used (Fig. 5E,F), and did not express LNGFR (data not shown). Low levels of nestin 
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Figure 5. Expression of Schwann cell phenotype by neural crest-derived glia. 
Clones were allowed to develop on pDL/FN for a week in standard medium, 
then transferred into Schwann cell differentiation (SCD) medium and allowed to grow 
for another 1-2 weeks prior to fixation and immunocytochemistry. Two separate 
double labeled clones are shown here in phase contrast (A, D). The clones were 
stained with 04 (B) and rabbit anti-Po (C), or with monoclonal anti-GFAP (E) and 
rabbit anti-Po. The same clones also contained neurons (not shown). The scale bar in 
panel F corresponds to a length of 50 11m. 
59 
60 
Figure 6. Multipotency of neural crest cells. 
A clone from a single founder cell shown in phase contrast (A) and expressing 
LNGFR (B) was allowed to proliferate and differentiate in standard medium 
(containing CEE and lacking serum) and then transferred into SCD medium (containing 
serum and forskolin). After approximately 10 days, the culture was fixed and triple-
labeled with rabbit anti-peripherin (C and D, in green/yellow), anti-GFAP (lgG) (C, in 
red) and 04 (lgM) (D, blue). Panels C and Dare 2 separate fields from the same clone. 
The scale bar in panel D corresponds to a length of 50 11m. 
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immunoreactivity could occasionally be detected in these cells. Due to our inability to 
identify these cells with available markers, we have termed them "other" (0) cells. A 
small percentage(< 10%) of neural crest cells that were LNGFR+ at 24 hrs after plating 
generated clones that consisted only of "0" cells (see below, Figs. 10 and 11 ). 
Inclusion of 10% FBS in the medium greatly increased the proportion of such purely 
"0" clones (D.L. Stemple, unpublished observations). This suggests that the "0" 
phenotype may represent a third, presently unidentified, non-neuronal fate of the neural 
crest cells which is also sensitive to environmental factors. 
Taken together, the foregoing data indicate that single neural crest cells (Fig. 
6A,B) expressing nestin and LNGFR are able to give rise to clones of differentiated 
cells containing both peripheral neurons and glia, as well as a third unidentified cell 
type. Differentiation to the neuronal phenotype involves the loss of nestin and LNGFR 
expression, and the acquisition of neuronal markers such as neurofilament, high-PSA 
NCAM and peripherin. By contrast, in the glial lineage LNGFR and nestin expression 
are retained, and under appropriate differentiation-inducing conditions additional glial 
markers (GFAP, 04 and PO) are acquired. Taken together, these data establish the 
multipotency of the LNGFR+, nestin+ rat neural crest cells. 
Self-renewal of multipotent neural crest cells in vitro 
The observation that a single neural crest cell gives rise to multiple differentiated 
derivatives does not distinguish whether the immediate progeny of a multi potent cell are 
themselves multipotent, or whether they are already restricted to different sublineages. 
To distinguish these possibilities, we performed a serial subcloning experiment. 
Primary clones founded by LNGFR+ progenitor cells (Figure 7A) were allowed to 
grow for 6 days on a pDL/FN substrate. Clones were then picked and replated at 
clonal density under the same conditions as their founder cells. Individual secondary 
founder cells were identified visually to ensure that all secondary colonies in fact 
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derived from single cells (Figure 7B,B '). Although on average 50% of these identified 
founder cells died (Table 1), after 10 days many of the surviving subclones were 
observed to contain neurons, identifiable by their rounded cell bodies and network of 
neurites (Figure 7C,C\ These subclones were then transferred to SCD medium and 
allowed to mature for another week, at which point they were fixed and double-labeled 
with antibodies to GFAP and neurofilament. This analysis confirmed that, like primary 
clones, these secondary subclones contained not only peripheral neurons, but GFAP+ 
(Fig. 8B) and Po+ (not shown) glial cells as well. 
From a total of 16 different primary founder clones analyzed in two separate 
experiments, 75% gave rise to at least one secondary clone containing neurons, glia and 
other cells (Table I, N+G+O). Moreover, in the second experiment (Table I, clones 
5.2-8.5), 100% of the founder clones gave rise to at least one N+G+O subclone. 
These data indicate that a high proportion of primary neural crest cells are capable of 
self-maintenance. Furthermore, 50% of the primary clones evaluated gave rise to 
multiple multipotent secondary subclones; for example, one founder cell gave rise to 15 
multi potent subclones (Table I, clone 1.1 ). On average, 54 ±11% of the surviving 
secondary clones derived from each primary founder were multipotent, i.e., contained 
both neurons, glia and "other" cells. These data show not only that multipotent neural 
crest cells are capable of self-renewal, but also indicate that self-renewal does not occur 
exclusively via asymmetric cell divisions, otherwise only one multipotent clone would 
be found among each set of secondary clones. 
In several cases secondary clones containing several neurons but no other cell 
type were found (Table I, N only). The number of cells in these N only clones was 
small ( < 10), and such clones were rarely observed in the primary clone population. In 
addition, many secondary clones contained glia and other cells but no neurons (Table I, 
G+O). Some of these non-neurogenic clones, moreover, contained only LNGFR+ 
glial cells and no LNGFR- "other" cells, suggesting the eventual generation of 
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Figure 7. Self-renewal ofmultipotent neural crest cells. 
(A), primary clone derived from a single LNGFR+ founder cell, photographed 
live after 7 days in culture. This same clone was dissociated by trypsinization and 
replated at clonal density. Two of the progeny subclone founder cells are shown in (B) 
and (B'). These two cells were allowed to form clones and photographed live after 17 
days (C, C'). Both non-neuronal and neurite bearing cells are visible in the clones. 
Some of the clones were then transferred into SCD medium, fixed and stained after an 
additional period of culture (see Figure 7 .). The scale bar in panel B' corresponds to a 
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Table I. Quantification of self-renewal in clonal neural crest cultures. 
Primary neural crest clones were subcloned and the phenotypic composition of 
their progeny secondary clones recorded as "N only" (multiple neurons but no glia), 
"N+G+O" (neurons, glia and other); "G+O" (glia and other), or "No clone found" 
(i.e., the secondary founder cell failed to form a sutviving clone). For both primary 
and secondary clones, the clonal nature of the colonies was verified by identifying and 
circling individual LNGFR+ founder cells on the plate. For each primary clone (plate 
number.clone number), the total number of secondary founder cells identified is given 
in column two. The total number of subclones of each phenotype is indicated in the 
subsequent columns. The percentage of total subclones represented by each phenotype 
is given in parentheses. The mean numbers are given either as the percentage of total 
subclone founder cells identified, or as the percentage of clonogenic founders; i.e., 
sutviving secondary clones. These means were calculated separately for each primary 
clone and the average of this number ±SEM was calculated. Note that the predominant 
clone type found among the sutviving subclones is of the N+G+O type, i.e., 
multi potent. Clones in the "G+O" category included some containing only LNGFR+ 
cells. The data are derived from two independent experiments (plates 1-4, and 5-8). A 
total of 16 primary founder cells and 151 secondary founder cells were analyzed. 
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Table I. Quantification of self-renewal in clonal neural crest cultures 
Sl!Q-C!Qn~; ~h~;nQl;ti21: lQllll# (2''2) 
Primary Clone # of2° ~ .!::ttQ±Q Q..±_Q _Q__ ~QI;jQn!: 
ID Founders fm!rul 
1.1 21 0 15 (71) 0 0 6 (29) 
1.18 6 0 1 ( 17) 1 (17) 2 (33) 2 (33) 
1.24 5 1 (20) 0 I (20) 2 (40) 1 (20) 
2.6 7 0 0 1 (14) 1 (1&) 5 (72) 
2.18 7 0 0 1 (14) 0 6 (86) 
3.14 20 0 2 (10) 4 (20) 0 14 (70) 
3.18 4 0 1 (25) 0 0 3 (75) 
4.5 I 0 1 (100) 0 0 0 
4.8 9 0 0 1 (11) 2 (22) 6 (67) 
4.14 10 0 2 (20) 3 (30) 1 (10) 4 (40) 
5.2 15 I (7) 8 (53) 0 0 6 (40) 
6.1 13 0 2 (15) 2 (15) 0 9 (70) 
6.2 17 1 (6) 2 (12) 4 (24) 0 10 (58) 
6.17 2 0 1 (50) 0 0 1 (50) 
8.2 5 0 4 (80) 0 0 1 (20) 
8.5 9 0 4 (44) 0 0 5 (56) 
Mean±s.e.m. 
% of total founders 2.1 ± 1.3 31±7.9 10 ± 2.6 7.4±3.3 49±6 
% of clonogenic founders 3.1±1.8 54± 11 29± 8 15 ± 6 
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Figure 8. Multipotency of secondary founder cells. 
A clone derived from secondary founder cells such as that shown in Figure 6 
was transferred into SCD medium to allow the expression of Schwann cell markers. 
After approximately 10 days the subclone was fixed, and double-labeled (B) for 
Peripherin (Yellow/Green) and GFAP (Red). The scale bar in panel B corresponds to a 
length of 50 IJ.m. 
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Schwann cell "blast" cells. In support of this idea, in separate experiments we have 
found that subcloning of clones initially containing LNGFR+ and LNGFR- cells 
produces both purely LNGFR+ and purely LNGFR- subclones (D.L. Stemple, 
unpublished observations). Taken together, these data suggest that although 
mammalian neural crest cells are capable of self-renewal, under some conditions they 
may eventually generate progeny with more restricted developmental potential. 
The fate of multipotent neural crest cells is influenced by their substrate 
The foregoing experiments indicate that neural crest cells grown on a pDL/FN 
substrate generate clones containing both peripheral neurons and glia. When the same 
cell population is grown at clonal density on a substrate containing FN only, the 
resulting clones contain LNGFR+ non-neuronal cells and 0 cells, but no neurons 
(Figure 9, compare C vs. F). By contrast, on pDL/FN the clones contain both 
LNGFR+, 5A5- non-neuronal cells and LNGFR-, 5A5+ neurons (Figure 9B, C). 
Quantification indicated that on FN alone, 70-80% of the clones are of the G+O 
phenotype and none of the N+G+O phenotype (Figure 1 OA), whereas on pDL/FN 60% 
of the clones are of the N+G+O phenotype and only 20% of the G+O phenotype 
(Figure lOB). These data indicate that the composition of the substrate affects the 
cellular phenotype of neural crest clones that develop in culture. 
Since in these experiments a population of dissociated neural crest cells is plated 
on either of two different substrates, the preceding results could be explained 
simply by the failure of neurogenic crest cells to adhere and survive on a FN substrate. 
To address this possibility, a different experiment was performed in which all of the 
crest cells were initially plated on a FN substrate. Thus differences in initial attachment 
and/or survival would not account for differences in eventual clone composition. After 
either 24 hrs or 4 days of culture, clones containing LNGFR+ crest cells were 
identified by live-labeling and circled. Purely "0" clones were not further analyzed 
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Figure 9. Neuronal differentiation of mutipotent neural crest cells is affected by their 
substrate. 
Primary clones established from single LNGFR+ founder cells plated on either 
pDL/FN (A-C) or FN alone (D-F) were double-labeled with monoclonal anti-LNGFR 
(IgG) (B, E), and monoclonal anti-high PSA NCAM (lgM) (C, F). Labeling was 
distinguished using class specific secondary antibodies. Neurite-bearing cells (A) 
expressing NCAM (C) are obtained on pDL/FN but not on FN (D, F). Clones on both 
substrates contain LNGFR + cells (B, E). However the intensity of LNGFR labeling is 
lower on pDL/FN, possibily reflecting the known ability of axonal contact to down-
regulate LNGFR expression on Schwann cell. The scale bar in panel F corresponds to 
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Figure 10. Phenotypic composition of clones grown on FN and pDL/FN at day 10. 
Clones derived from LNGFR+ neural crest founder cells were established on 
either FN (A) or pDL/FN (B) substrates. After 10 days, the cultures were fixed and the 
phenotype of the clones determined by labeling with anti-LNGFR and anti-high PSA 
NCAM (see Fig. 9). The proportion of clones containing neurons, glia and other 
(N+G+O) cells, glia and other cells but no neurons (G+O), other cells only (0) or dead 
(those founder cells which failed to form clones) was calculated. The values plotted 
represent the mean ±SEM from over 100 clones in 4 separate experiments. Note that 
no neuron-containing clones are found on FN (A), whereas 60% of the clones contain 
neurons on pDL/FN (B). 
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since these clones generate neither neurons nor glia under any conditions so far 
examined (see above). Following LNOFR staining, one group of clones was exposed 
to pDL as an overlay, while a set of sister clones was maintained on FN alone as a 
control. After 10 days the cultures were transferred to SCD medium for an additional 2 
weeks of culture, and the clone phenotypes then scored as previously described. 
By contrast to clones maintained on FN, where no neurons developed, many of 
the clones exposed to a pDL overlay at 24 hrs contained neurons at the end of the 
culture period (Figure llA, shaded bars, N+O+O). Furthermore, virtually none of the 
clones were of the G+O phenotype after the pDL overlay (Fig. llA, shaded bars, 
G+O). These data suggest that at least some of the N+G+O clones were derived by 
conversion of founder cells that would have produced 0+0 clones if maintained on 
FN. But since application of pDL at day 1 yielded significant cytotoxicity, we could 
not rule out the possibility that many cells that would have produced 0+0 clones, even 
in pDL, simply died. However, when the pDL overlay was performed on LNOFR+ 
clones at day 4 most of the clones survived the overlay, probably because there were 
more cells in each clone at the time pDL was applied (compare shaded bars, "Dead," in 
Fig. 11A,B). Under these conditions, 60% of the starting clones generated neurons 
and glia (Fig. 11 B, shaded bar, N+G+O), whereas 35% generated glia but not neurons 
(Figure 11B, shaded bar, 0+0). By contrast, virtually all of the control clones 
identified at day 4 and maintained on FN developed to a 0+0 phenotype (Fig. 11B, 
hatched bars). Since essentially all clones in the day 4 cohort were recovered live 
following the overlay, these data imply that pDL must have converted a high proportion 
of presumptive G+O clones into N+O+O clones. The fact that 35% of the clones still 
became 0+0 following pDL overlay at day 4, whereas virtually none did so when the 
overlay was applied at 24 hours (Figure 11, compare 0+0, shaded bars, in A and B), 
suggests that either some clones become resistant to the effect of pDL between 24 hours 
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Figure 11. Development of neurons in clones plated on FN and subsequently 
overlayed with pDL. 
Neural crest clones were established on FN and overlayed with pDL after either 
24 hours of secondary culture (A), or 4 days of secondary culture (B). After a further 
incubation clone composition was scored as in Figure 10. Shaded bars represent 
clones overlayed with pDL; hatched bars represent control sister clones maintained on 
FN. The percentage of final G+O clones (90%) from the day 4 cohort is higher than 
that obtained from the day 1 cohort (65%), because 35% of the single LNGFR+ cells 
identified at day 1 subsequently lost LNGFR and developed into 0 clones (Panel A, 
hatched bars, 0). In contrast, by day 4 all LNGFR+ clones contained multiple 
LNGFR+ cells so that purely 0 clones rarely developed from this cohort (Panel B, 
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Table II. Alteration of neural crest cell clone fate by subculture onto different substrates 
Neural crest clones were established on either FN or pDL/FN ("Primary 
Substrate"), and then sub-cultured after 5 days. Cells from each primary clone were 
replated at clonal density onto either FN or pDL/FN ("Secondary substrate"). The 
phenotypic composition of resulting sub-colonies was analyzed ten days later. "+" 
indicates that one or more sub-colonies of a primary clone contained neurons under that 
condition. "-" indicates that no neurons were found in any sub-colonies of the primary 
clone. The fractions represent the proportion of total primary clones analyzed that 
generated any neuron-containing sub-colonies. 
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and 4 days of culture, or that a greater number of presumptive G+O clones survived 
following the pDL overlay at day 4. 
Clonal culture on fibronectin precludes overt neuronal differentiation 
but permits the maintenance of neurogenic potential 
The preceeding experiment provides statistical evidence that neural crest clones 
grown on FN are unable to differentiate into neurons, but retain the capacity to do so 
when subsequently exposed to pDL. A more direct test of this idea would be to plate 
clones on FN and then to sub-culture them onto pDL/FN; such cells should generate 
neuron-containing sub-colonies, sister cells sub-cultured onto FN should not. To this 
end, a cohort of clones was initially established on FN and after 5 days each clone was 
picked and replated at clonal density onto both FN and pDL/FN substrates. The 
replated cells were allowed to grow and mature in culture, and the resulting colonies 
were scored for the presence of cells bearing a neuronal morphology. In striking 
contrast to their sister cells subcloned onto FN, which failed to generate any neuron-
containing clones, five out of seven primary clones transferred from FN to pDL/FN at 
day 5 gave rise to colonies that contained neurons (Table II). Among these sub-
colonies transferred to pDL/FN, on average, 57± 17% contained neurons. 
Conversely, 0/5 primary clones founded on pDL/FN generated neurons when 
subcultured onto FN , although these clones all generated neuron-containing subclones 
when replated onto pDL/FN (Table II). Thus, sub-culture on pDL/FN permits overt 
neuronal differentiation by neural crest cells initially plated on FN; conversely sub-
culture on FN precludes overt neuronal differentiation by cells initially plated on 
pDL/FN. These data indicate that the composition of the substrate is able to control the 
overt neuronal differentiation of neural crest cells. However, since the capacity to 
produce neurons is retained for some time on FN, overt neuronal differentiation can 
apparently be controlled independently of neurogenic potential. 
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Discussion 
The properties of stem cells have been characterized primarily in adult tissues 
capable of self-renewal or regeneration in response to injury, such as skin, intestine and 
blood. These properties include the ability to self-renew, divide asymmetrically and to 
generate one or more irreversibly differentiated progeny cell types (Hall and Watt, 
1989; Potten and Loeffler, 1990). Progress in the characterization of different 
mammalian stem cell populations has been hampered by the difficulty of obtaining 
adequate cell markers, and of establishing functional assay systems. It has been widely 
assumed that the neuroepithelial precursor cells of the vertebrate CNS and PNS are 
stem cells (McKay, 1989). However, there has been only indirect evidence in support 
of this idea (Temple, 1989). Here we describe the properties of isolated mammalian 
neural crest cells in vitro. We show that these cells are multipotent, generate 
differentiated progeny, divide asymmetrically and are capable of self renewal. By these 
criteria, neural crest cells exhibit the properties of stem cells. 
Mammalian neural crest cells are multipotent 
Like their avian counterparts (Sieber-Blum and Cohen, 1980; Baroffio et al., 
1988), the rat neural crest cells we have isolated are multipotent. Under our present 
culture conditions, these cells are able to generate glia, neurons and at least one other 
unidentifiable cell type. Using a panel of antibody markers, we have identified the glial 
cells as Schwann cells. Similarly, we have characterized the neurons using a battery of 
markers that include NCAM, neurofilament and peripherin, an intermediate filament 
protein preferentially expressed in the PNS (Parysek and Goldman, 1988). Although 
these markers identify the neurons as peripheral, their precise identity is unclear. They 
do not express markers characteristic of noradrenergic sympathetic neurons, such as 
tyrosine hydroxylase (TH). However, the neurotransmitter phenotype of sympathetic 
neurons is known to be plastic (Patterson and Chun, 1977; Landis and Keefe, 1983), 
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so we cannot exclude the possibility that these neurons are in fact sympathetic. On the 
other hand, the neurons could represent one or more non-catecholaminergic lineages 
such as sensory, parasympathetic and enteric. Unfortunately, definitive markers for 
these sub-lineages have not yet been described in mammals. 
Other non-neuronal cell types known to derive from the neural crest include 
melanocytes and mesectodermal cells such as chondrocytes. In vivo, mesectodermal 
lineages normally develop only from the cephalic neural crest (LeDouarin, 1982), and 
transplantation experiments in chick suggest that the trunk region lacks mesectodermal 
potential (LeDouarin, 1980). While melanocytes originate from all regions of the crest, 
for various reasons albino rats proved a superior source of crest cells for these 
experiments. It is conceivable that the 0 cells represent melanocytes or their 
progenitors. 
Mammalian neural crest cells undergo self-renewal 
By performing serial subcloning experiments we have been able to demonstrate 
that multipotent neural crest cells, expressing an LNGFR+, nestin+, lineage- antigenic 
phenotype, give rise to clonal progeny which are themselves multi potent and express 
the same markers. Thus, by both antigenic and functional criteria multipotent neural 
crest cells are capable of self-renewal. This observation suggests that in vivo, the 
progeny of proliferating neural crest cells are not immediately restricted to different 
sublineages. Rather, these cells may maintain their multipotency as they migrate and 
colonize various structures throughout the embryo. Consistent with this notion, 
migrating neural crest cells in the somitic mesenchyme have been shown to be 
multipotent in vivo (Fraser and Bronner-Fraser, 1991), and clonal analysis of cells 
from early avian sensory and sympathetic ganglia has revealed multipotency in vitro 
(Duff et al., 1991; LeDouarin et al., 1991 ). 
Experiments to assess further the extent of neural crest cell self-renewal capacity 
are currently in progress. We have performed serial subcloning experiments as late as 
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day 11 when clones appear to contain >500 cells (9 cell divisions), and found that> 
50% of the sub-clones exhibit multi potency (not shown). While the accepted definition 
of a stem cell usually includes extensive or "unlimited" self-maintenance capacity (Hall 
and Watt, 1989), it is also accepted that the extent of self-maintenance may be subject to 
environmental regulation (Potten and Loeffler, 1990). Self-maintenance in a stem cell 
lineage may be achieved if individual cell divisions are asymmetric, producing one stem 
cell and a different sister (blast) cell. However, in some lineages such asymmetry may 
be a property of the cell population rather than of individual cells; i .e., all cell divisions 
are symmetric, but approximately half the time produce two stem cells and half the time 
two blast cells (Potten and Loeffler, 1990). If the probability of self-renewing 
divisions is environmentally-controlled, then under conditions where that probability is 
>0.5 the stem cell population will increase in size; if it is < 0.5 the stem cells will 
eventually be exhausted. Stem cells populations may therefore exhibit finite self-
renewal under some conditions. 
Unlimited self-maintenance capacity is generally a property of stem cells found 
in regenerating tissues, such as skin, intestine and the hematopoietic system. The 
mammalian nervous system has traditionally been thought to lack extensive regenerative 
capacity. On the other hand, evidence has recently been presented for an adult glial 
progenitor cell in the optic nerve (Wolswijk and Noble, 1989), and apparently 
bipotential progenitors have been identified in the adult mouse striatum (Reynolds and 
Weiss, 1992). Thus the regenerative capacity of the mammalian nervous system may 
be more extensive than previously thought. It will be of future interest to determine 
whether neural crest cells contibute to this regenerative capacity. 
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The composition of the substrate can control the fate of neural crest 
cells 
The fate of neural crest cell populations can be altered by their local environment 
in vivo (LeDouarin, 1980; LeDouarin, 1982). However, little is known about the 
identity of the environmental signals that influence neural crest cell fate, or how these 
signals act on individual neural crest cells. We have shown that multi potent neural crest 
cells generate different derivatives when cultured on different substrates: both neuronal 
and non-neuronal cells are generated on pDL/FN whereas on FN only non-neuronal 
cells are generated. Both the pDL overlay and cross-subcloning experiments rule out 
the possibility that the substrate acts selectively to promote the differential attachment of 
neurogenic and non-neurogenic neural crest cells present in the starting cell population. 
Furthermore, continuous observation of clones indicates that neurons do not appear 
transiently on a FN substrate. It thus appears unlikely that the pDL/FN substrate acts 
selectively to permit the survival of neurons that are initially generated at equal 
frequency on both substrates. Whether the substrate conditions we have defined 
control a choice between neuronal and non-neuronal directions of differentiation, or 
rather influence the overt expression of a latent neuronal differentiation program, 
remains an open and interesting question. The notion that different environments can 
influence the fate of multi potent neural crest cells fits well with data suggesting that the 
progeny of a single neural crest cell express different phenotypes in different locations 
in vivo (Bronner-Fraser and Fraser, 1988; Bronner-Fraser and Fraser, 1989; Fraser 
and Bronner-Fraser, 1991). 
The observation that neural crest clones founded on a pDL/FN substrate fail to 
produce neurons when subcultured on FN suggests that FN is either non-permissive 
for, or inhibitory to, neuronal differentiation. Consistent with this idea, preliminary 
observations indicate that multipotent neural crest cells plated at clonal density on 
untreated tissue culture plastic are able to generate neurons, by contrast to cells plated 
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on FN-coated dishes. Clones grown on fibronectin appear more disperse than those 
grown on untreated plastic or on pDL/FN. This suggests that culture on a FN substrate 
may preclude neuronal differentiation by inhibiting cell-cell interactions. In vivo, FN 
has been demonstrated to be present on the routes followed by migrating, 
undifferentiated crest cells (New green and Thiery, 1980). Our results suggest that this 
substrate molecule may not only favor cell migration, but may also prevent premature 
neuronal differentiation by promoting cell dispersal. Consistent with this view, 
neuronal differentiation in vivo is associated with the aggregation of neural crest cells to 
form ganglion primordia. Such aggregation is correlated with the expression of cell 
adhesion molecules such as N-cadherin (S. Fraser, personal communication), which 
may counteract the effects of FN. Similarly, in our culture system poly-D-lysine may 
act to override the dispersal promoting activity of FN; in this respect it may mimic the 
action of a natural molecule in vivo. 
Developmental fate versus developmental potential 
When neural crest cells are subcloned from FN onto pDL/FN within the first 
few days of culture, they are able to generate clones containing both neurons and 
Schwann cells. This result indicates that although the fate of cells on FN would have 
been to generate only glia, such cells nevertheless have neurogenic potential (Fig. 12 
upper, B and C). This suggests that in vivo, some neural crest cells that generate 
clones containing only glia (Bronner-Fraser and Fraser, 1989; Frank and Sanes, 1991; 
LeDouarin et al., 1991) may in fact be multipotent, but may manifest only one of their 
developmental capacities due to their local environment. A more general restatement of 
this notion is that although the progeny of a single neural crest cell may generate 
different derivatives at different times or different places in vivo, the developmental 
potentials of these progeny cells may be equivalent (Figure 12 upper, A). Such a 
mechanism would be consistent with the observation that multi potent crest cells are 
capable of self-renewal. 
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Figure 12. Schematic illustration of neural crest cell fate vs. developmental potential. 
Upper: (A) Hypothetical in vivo crest lineage in which a dividing crest cell 
gives rise to different cell types in different environments. It cannot be determined 
whether the developmental potentials of the undifferentiated cell (Ul) and its daughter 
(U2) are equivalent. (B) The fate of an undifferentiated crest cell (U2) grown on 
fibronectin in vitro is to generate glia but not neurons; however the neurogenic potential 
of its daughter is revealed by serial subcloning onto pDL/FN (C). Therefore 
undifferentiated cells U2 and Ul have the same developmental potential. 
Lower: Summary diagram indicating the in vitro behavior of neural crest stem 
cells defined in this study. St, stem cell; Pg, glial progenitor; Pn, neuronal progenitor; 
G differentiated glial cell; N differentiated neuron; 0, "other" unidentifiable cell. 
B. 
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On the other hand, our serial subclonal analysis has also revealed that some 
secondary subclones contain only neurons (Table II), a clone composition never 
observed among primary clones. Moreover, in preliminary experiments (D. Stemple 
and D. Anderson, unpublished observations) we have found that when neural crest 
cells are subcloned from FN to pDL/FN after a more extended culture period, many 
subclones fail to generate neurons although glial differentiation capacity is retained. 
This suggests that under some conditions, multipotent neural crest cells may generate 
progeny that do not have neurogenic potential (Fig. 12, lower). The generation of such 
lineally-restricted progeny from multipotent progenitor cells is consistent with a 
progressive model of neural crest development. The timing, mechanism and 
environmental control of such developmental restrictions remain to be investigated 
further. 
In summary, our data support the idea that the early stages of neural crest cell 
lineage segregation involve the self-renewal of multi potent stem-like cells, analagous to 
the early stages of hematopoiesis (Spangrude et al., 1988; Ikuta et al., 1992). In the 
immune system, substantial progress has been made in identifying factors controlling 
the development of hematopoietic progenitor cells (Metcalf, 1989; Dexter et al., 1990). 
Interestingly, an increasing number of hematopoietic growth factors have been shown 
to have biological effects on neurons and neuronal precursor cells (Nawa et al., 1990; 
Ip et al., 1992), suggesting that the relationships between hematopoiesis and 
"neuropoiesis" (Anderson, 1989) may extend beyond mere analogy (Bazan, 1991) The 
isolation of neural crest stem cells now provides an assay system to investigate the roles 
of these and other growth factors in peripheral nervous system development, at the 
single-cell level. In addition, our culture system provides an assay for neural crest stem 
cells in tissues at later stages of development. Such studies should not only contribute 
to our understanding of basic stem cell biology and neural development, but may also 
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have therapeutic applications in the treatment of neurologic and neurodegenerative 
disease. 
Experimental procedures 
Neural crest cell preparation 
For a given preparation 5-10 timed pregnant female Sprague-Dawley rats 
(Simonson Laboratories, Gilroy, CA) were killed by C02 asphyxiation, as approved 
by the California Institute of Technology Animal Care Committee in accordance with 
National Institutes of Health guidelines. Embryos were removed and placed into 
Hank's Balanced Salt Solution (HBSS) (GIBCO, Grand Island, NY) at 4°C for 2-4 
hours. Under a dissecting microscope, at room temperature, a block of tissue from a 
region corresponding approximately to the caudal most 10 somites was dissected from 
each embryo using an L-shaped electrolytically sharpened tungsten needle. Trunk 
sections were transferred in HBSS into one well of a 3 well depression slide that had 
been chilled to 4°C. Trunk sections were treated with collagenase (152 
units/mg)(Worthington Biochemical, Freehold, NJ) made to a concentration of 0.75 
mg/rnl in Howard's Ringer's solution (per 1 liter of dH20: NaCl 7.2g; CaC12 0.17g; 
KCl 0.37 g) and sterilized by passage through a 0.22 J.lm filter prior to use. The 
collagenase solution was exchanged at least 3 times and with each exchange the trunk 
sections were vigorously triturated. After incubation at 37°C for 20 minutes in 
humidified C02 atmosphere, the trunk sections were triturated very gently until most of 
the neural tubes were clean and free of sornites and notochords. The collagenase 
solution was quenched by repeated exchanges with cold standard medium (SM) 
(medium composition described below). The neural tubes were plated onto fibronectin-
coated (substrate preparation is described below) 60 mm tissue culture dishes (Coming, 
Corning, NY) that had been rinsed with SM. After a 30 minute incubation to allow the 
neural tubes to attach, dishes were flooded with 5 ml of SM. After a 24 hour culture 
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period, using an L-shaped electrolytically sharpened tungsten needle and an inverted 
phase contrast microscope equipped with a 4X objective lens, each neural tube was 
carefully scraped away from the neural crest cells that had migrated onto the substrate. 
Neural crest cells were removed by a 3 minute 37°C treatment with 0.05% Trypsin 
solution (GIBCO). The cells were centrifuged for 4 minutes at 2000 r.p.m. and the 
pellet was resuspended into 1 ml of fresh SM. Typically the cells were plated at a 
density of 225 cells I 1 OOmm dish. 
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Media and additives 
A. Chemically defmed medium 
The basal medium used in all experiments is a chemically defined medium that 
we developed based on the recipes of several other defined media. The medium 
consists ofL-15 C02 formulated as described by Hawrot and Patterson (Hawrot and 
Patterson, 1979), supplemented with additives described by Bottenstein and Sato 
(Bottenstein and Sato, 1979; Wolinsky et al., 1985), and further supplemented with the 
additives described by Sieber-Blum and Chokshi (Sieber-Blum and Chokshi, 1985). 
The recipe is given here: to L-15 C02 add, 100 IJ.g/ml transferrin (Calbiochem, San 
Diego, CA), 5 IJ.g/ml insulin (Sigma, St. Louis, MO), 16 IJ.g/ml putrescine (Sigma), 20 
nM progesterone (Sigma), 30 nM selenious acid (Sigma), 1 mg/ml bovine serum 
albumin, crystallized (GIBCO), 39 pg/ml dexamethasone (Sigma), 35 ng/ml retinoic 
acid (Sigma), 5 IJ.g/ml a-d, 1-tocopherol (Sigma), 63 IJ.g/ml ~-hydroxybutyrate 
(Sigma), 25 ng/ml cobalt chloride (Sigma), 1 IJ.g/ml biotin (Sigma), 10 ng/ml oleic acid 
(Sigma), 3.6 mg/ml glycerol, 100 ng/ml a-melanocyte stimulating hormone (Sigma), 
10 ng/ml prostaglandin E1 (Sigma), 67.5 ng/ml triiodothyronine (Aldrich Chemical 
Company, Milwaukee, WI), 100 ng/ml epidermal growth factor (Upstate 
Biotechnology, Inc., Lake Placid, NY), 4 ng/ml bFGF (UBI), and 20 ng/ml 2.5S 
NGF (UBI). Each concentration given is the final concentration in the medium. In 
general each additive was dissolved to a crude stock concentration and then diluted 
further to a 1000X stock concentration in L-15 C02 and then stored at -80°C. Most 
additives were dissolved in dH20 with the exception of the following: Biotin was 
dissolved to a crude stock concentration of 10 mg/ml in DMSO; Prostaglandin was 
dissolved in 95% ethanol to a crude stock concentration of 1 mg/ml; Triiodothyronine 
was dissolved in DMSO to a crude stock concentration of 10 mg/ml; Retinoic acid was 
dissolved in DMSO to a crude stock concentration of 17.5 mg/ml and then diluted to a 
1 OOOX concentration in a 1:1 mixture of 95% ethanol and L-15 C02; and a-d, 1-
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tocopherol was dissolved to a 1000X stock concentration of 5 mg!ml in DMSO. The 
final solvent concentrations are 0.11% DMSO (v/v) and 0.07% ethanol (v/v). 
Transferrin, insulin, selenious acid, putrescine, and progesterone were prepared as 
described by Wolinsky and Patterson (Wolinsky et al., 1985). 
B . Chick embryo extract 
For most experiments standard medium (SM) was used. SM was made by 
further supplementing the chemically defined medium with 10% chick embryo extract 
(CEE). To prepare CEE, white leghorn chicken eggs were incubated for 11 days at 
38°C in a humidified atmosphere. Eggs were washed and the embryos were removed, 
and placed into a petri dish containing sterile Minimal Essential Medium (MEM with 
Glutamine and Earle's salts) (GIBCO) at 4°C. Approximately 10 embryos each were 
macerated by passage through a 30 m1 syringe into a 50 ml test tube (Corning). This 
typically produced -25 m1 of homogenate to which was added 25 ml of MEM. The 
tubes were rocked at 4°C for 1 hour. Sterile hyaluronidase (1 mg I 25 g of embryo) 
(Sigma) was added and the mixture was centrifuged for 6 hours at 30,000 g. The 
supernatant was collected, passed first through a 0.45 ~m filter, then through a 0.22 
~m filter and stored at -80°C until used. 
C. FBS and forskolin 
For some experiments the medium was further supplemented with fetal bovine 
serum (FBS) and forskolin. The FBS was obtained from JR scientific and was heat 
inactivated by treatment at 55°C for 30 minutes. The FBS was stored at -20°C and 
passed through a 0.22 ~m filter prior to use. Forskolin was obtained from Sigma as a 




Tissue culture dishes were coated with human plasma fibronectin (New York 
Blood Center, New York, NY) in the following way. Lyophilized fibronectin was 
resuspended in sterile distilled water (dH20) to a concentration of 10 mg/ml and stored 
at -80°C until use. The fibronectin stock was diluted to a concentration of 250 11g/ml in 
Dulbecco's phosphate buffered saline (D-PBS) (GIBCO). The fibronectin solution 
was then applied to tissue culture dishes and immediately withdrawn. 
B. poly-D-lysine 
Sterile poly-D-lysine (pDL) (MW 30-70 kDa) (Biomedical Technologies, Inc., 
Stoughton, MA) was dissolved in dH20 to as concentration of 0.5 mg/ml. The pDL 
solution was applied to tissue culture plates and immediately withdrawn. The plates 
were allowed to dry at room temperature, rinsed with 5 ml of dH20 and allowed to dry 
again. Fibronectin was then applied, as described above, over the pDL. 
For pDL overlay experiments, dishes were rinsed once with L-15 medium 
(GIBCO), then treated for 3 minutes with a solution of 0.05 mg/ml pDL in L-15. The 
dishes were rinsed twice with L-15 and then refed with SM. 
Cloning procedure 
Cloning of cells was accomplished by first plating cells at a low density of -225 
cells/lOOmm dish, allowing the cells to attach and then identifying single cells with an 
inverted phase contrast microscope equipped with a 4X objective lens. The single 
founder cells were marked by inscribing a circle around them with a grease pencil on 
the bottom of the dish. The circles were made to a diameter of 3-4 mm, which was 
generally large enough to allow the unambiguous identification of the progeny of the 
founder at any time during an experiment. The dishes were stained for expression of 
LNGFR using the monoclonal antibody 192IgG (Chandler et al., 1984). The 192IgG 
antibody was produced by hybridoma cells grown in the chemically defined medium 
described above. The staining procedure used is described below. 
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Serial sub-cloning 
For serial sub-cloning experiments clones were harvested and re-plated as 
follows. The clones were examined microscopically to ensure that there were no 
impinging colonies and that the whole clone fit within the inscribed circle. Using sterile 
technique throughout the procedure, glass cloning cylinders (3 rnm i.d.) were coated on 
one end with silicone grease (Dow Coming, Midland, MI) and placed about the clone 
so that the grease formed a seal through which medium could not pass. The cells were 
removed from the cylinder by first treating them with 100 111 of 0.05% Trypsin solution 
(GIBCO) for 3 minutes at 37°C in a humidified 5% C02 incubator. At room 
temperature 70 111 of the trypsin solution was removed and replaced with 70 111 of SM. 
The cells were resuspended into the 100 111 volume by vigorous trituration and the 
whole volume was diluted into 5 ml of SM. The 5 ml was then plated onto one or two 
60 rnm dishes which were placed in a humidified 5% C02 incubator for 2 hours. The 
medium was then exchanged for fresh SM and single founders cells were identified as 
described above. 
Immunohistochemistry 
A. Live labeling, surface antigens 
For cell surface antigens it was possible to label the living cells in culture. The 
cultures were incubated with primary antibody solution for 20 minutes at room 
temperature. The cultures were washed twice with L-15 medium (GIBCO) 
supplemented with 1:1 :2, fresh vitamin mix (FVM) (Hawrot and Patterson, 1979), and 
1 mg/ml bovine serum albumin (L-15 Air). The cultures were then incubated for 20 
minutes at room temperature with Phycoerythrin-R conjugated secondary antibody 
(T AGO) at a dilution of 1 :200 in L-15 Air. The cultures were then rinsed twice with L-
15 Air and placed back in their original medium and examined with a fluorescence 
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microscope. Rabbit anti-LNGFR antiserum was a kind gift of Dr. Gisela Weskamp, 
University of California, San Francisco and was used at a 1:1000 dilution. Monoclonal 
anti-NCAM antibody 5A5 was obtained as hybridoma cells from the Developmental 
Studies Hybridoma Bank and prepared as described by the provider. Hybridoma cells 
producing the monoclonal anti-sulfatide antibody 04 were the gift of Dr. Monique 
DuBois-Dale (Nlli) and were grown in a medium consisting of RPMI-1640 (GIBCO), 




For most of the immunocytochemistry formaldehyde fixation was done. 
Formaldehyde solution 37% was diluted 1:10 into S-MEM with 1rnM HEPES buffer 
(GIBCO). Cultures were treated for 10 minutes at room temperature with the 3.7% 
Formaldehyde solution and then rinsed 3 times with D-PBS (GIBCO). 
ii. Acid/ethanol 
For some intermediate filament proteins (NF and GFAP) formaldehyde fixation 
was not possible. Cultures were fixed by treating with a solution of 95% ethanol and 
5% glacial acetic acid at -20°C for 20 minutes. 
C. Cytoplasmic antigens 
For the staining of cytoplasmic atigens, fixed cells were first treated with a 
blocking solution consisting of D-PBS, 0.1 % Tween-20 (Bio-Rad Laboratories, 
Richmond, CA), and 10% heat inactivated normal goat serum (NGS) for 15 minutes at 
room temperature. Primary antibodies were diluted into a solution of D-PBS, 0.1% 
Tween-20, and 5% NGS. The fixed cells were incubated overnight at 4°C in primary 
antibody solution then rinsed twice with D-PBS, 0.05% Tween-20. Fluorescent 
secondary antibodies were diluted into D-PBS, 1% NGS and applied to the cells for 1 
hour at room temperature. The cells were rinsed twice with D-PBS, 0.05% Tween-20. 
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To prevent photobleaching, a solution of 8 mg/rnl N-propyl gallate in glycerol was 
placed over the cells prior to fluorescence microscopy. 
Mouse monoclonal anti-glial fibrillary acidic protein (GFAP) antibody G-A-5 
(IgG) and mouse monoclonal anti-NF160 antibody NN18 (lgG) were purchased from 
Sigma and used at a 1:100 dilution. Mouse monoclonal anti-neurofilament heavy chain 
antibody SMI 39 (lgM) was purchased from Sternberger Monoclonals Inc., Baltimore, 
MD, and used at a dilution of 1:500. Purified rabbit antibodies to peripherin 
(preparation 199-6) was the kind gift of Dr. Linda Parysek, University of Cincinatti, 
OH, and was used at a dilution of 1:300. Rabbit antisera generated against Po were the 
kind gift of Dr. Jeremy Brockes (Morgan et al., 1991).(used at a dilution of 1 :200) or 
Dr. Greg Lemke (Trapp et al., 1979; Trapp et al., 1981 ). (used at a dilution of 1 :500). 
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Summary 
To define further the molecules that control sympatho-
adrenal differentiation, we have investigated the effects 
of FGF, NGF, and glucocorticoid on cultured neonatal 
rat adrenal chromaffin cells. Basic FGF (bFGF), like NGF, 
induces cell division and neurite outgrowth from these 
cells. Dexamethasone inhibits neuronal differentiation 
but not proliferation induced by bFGF. Unlike NGF, 
bFGF will not support the survival of chromaffin cell-
derived sympathetic neurons. However, bFGF induces a 
dependence on NGF. The overlapping but distinct re-
sponses to NGF and bFGF may underlie a sequence of 
events in sympathetic differentiation. bFGF (or another 
factor) may act locally in developing ganglia to stimu-
late mitotic expansion and initial axon outgrowth. Sub-
sequent survival and maturation are then controlled 
by NGF, which is provided by peripheral targets of in-
nervation. In the adrenal gland, glucocorticoids may 
permit bFGF to amplify the chromaffin population, 
while preventing neuronal differentiation. 
Introduction 
The neural crest is a transient neurcctodermal structure 
of the vertebrate embryo that gives rise to a variety of cell 
types including those of the 5ympathoadrenal lineage: 
the neurons of the sympathetic ganglia and the chro-
maffin cells of the adrenal medulla (le Douarin, 1982). 
In vitro studies have shown that chromaffin cells and 
sympathetic neurons can be derived from a common 
precursor (Doupe et al., 1985b; Anderson and Axel, 
1986). Interestingly, mature chromaffin cells can be in-
duced to transdifferentiate into sympathetic neurons by 
addition of nerve growth factor (NGF) and a factor in 
heart cell-conditioned medium (Unsicker et al., 1978; 
Doupe et al., 1985a). This effect i~ blocked by glucocor-
ticoid, suggesting that the high local concentra tion of 
steroids in the adrenal medulla may be important for the 
maintenance of an endocrine phenotype. In support of 
this, glucocorticoids arc required for the survival of rat 
chromaffin cel ls in vitro (Doupe et al., 1985a). In addi-
tion to inducing neuronal differentiation, NGF can simul-
taneously serve as a mitogen for these cells (Lillien and 
Claude, 1985). A cell line of adrenal medullary origin, 
PCI2, is also capable of adopting a neuron-like pheno-
type in I he presence of NGF (Greene and Tischler, 1976). 
These findings, in conjunction with the origin<JI cha rac-
terization of the role of NGF in the embryo (Levi-Montal-
cini, 1976), have established NGF as a mitogen and dif-
ferentiation agent, as well as a survival factor. 
Acidic and basic fibroblast growth factors (aFGF and 
bFGF), though originally characterized as potent milo· 
gens for a variety of cell types of mesodermal origin (for 
review, see Gospodarowicz et al., 1986b), have recently 
been demonstrated to support the survival of a variety 
of vertebrate neurons. Embryonic rat hippocampal neu-
rons, cerebellar granule cells, <~nd Purkinjc cells, as well 
as cortica l neuronal precursor cells, can all be sustained 
by bFGF in vitro (Walicke et al., 1986; Morrison et al., 
1986; Gensburgcr et al., 1987; Hallen et al., 1988). In ad-
dition, FGF supports the survival of chick parasym-
pathetic ciliary ganglion neurons (Unsicker et al., 1987). 
The response of PC12 cel ls to aFGF and bFGF is very 
simi 1M to their response to NGF (Togari et al., 1985; Wag-
ner and D'Amore, 1986; Neufeld et al., 1987; Rydel and 
Greene, 1987; Schubert et al., 1987). Thus far, FGF and 
NGF arc the on ly proteins known to be capable of in-
ducing neuron-specific mRNAs in PC12 cells (Leonard et 
al., 1987; Stein cl al., 1988a). 
The response of PC 12 cells to FGF raises the possibi lity 
that this factor may play a previously unanticipated role 
in the normal development of the sympathoadrenallin-
eage. To address this question, the actions of bFGF on 
primary cultures of neonatal rat adrenal chromaffin cells 
were examined and compared with those of NGF. 
Results 
bFGF Induces the Neuronal Differentiation of 
Chromaffin Cells 
The effects of bFGF (purified some 140,000-fold from 
bovine pituitary) on chromaffin cells were initially exam-
ined by measuring neurite outgrowth, a morphologic in-
dex of neuronal differentiation (Figu re 1; Figure 2). bFGF 
at a concentration of 10 ng/ml rapidly induced process 
outgrowth from cultured chromaffin cells (Figure 1E). 
The kinetics of this induction were roughly equivalent to 
those observed with NGF (Figure 2A, compare NGF and 
FGF, filled symbols), except that in bFGF the percentage 
of process-bearing cells reached a plateau of 83% at day 
6, whereas in NGF it cont inued to increase to 99% by 
clay 10. In agreement with observations reported for PC12 
cells (Neufeld el al., 1987; Rydel and Greene, 1987), it 
was found that the dose-response for neurite outgrowth 
from chromaffin cells was biphasic w ith respect to bFGF 
(Figure 2B), although this was less apparent after longer 
periods of exposure to the factor. 
Dexamethasone (dex) inhibits NGF-induced neurite 
outgrowth from chromaffin cells (Unsicker et al., 1978; 
Doupe et al., 1985a). It was therefore of interest to deter-
mine whether this synthetic glucocorticoid would have 
a similar effect on process outgrowth induced by bFGF. 
When cul tures were simultaneously exposed to bFGF 
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Figure I. Morphology of Chromaffin Cells Treated with bfGF, NGF, and/or dcx 
CC'IIS were grown for 6 days in growth medium alone (A) or in growth mcd•urn supplemented w1th the following factors: 1.0 ~M dex (B), 
1.0 ~g/ml 75 NGF (C), NGF plus dex (0), 10.0 ng/ml bFGF (E), and bFGF plus dex (f). fluorescence micrographs were taken of cultu res staoned 
with OX-7 monoclonal anti-Thy-1 antibody. Bar, 50 ~m. 
hibited by about 50% (Figure 2A, FGF, open symbo ls). 
However, the rate of accumulation of process-bearing 
cells was only slightly diminished by the steroid. In this 
culture condition, chromaffin cells were often found in 
large, flattened clusters bearing processes that were 
thicker, shorter, and less arborized than those observed 
in bFGF alone (compare Figures IE and IF). Furthermore, 
most process-bearing cells in bFGF plus dex did not ex-
p ress immunohistochemically detectable amounts of the 
neural-specific marker protein SCGIO (Stein et al., 19llllb) 
(da ta not shown). The quanti tative data may therefore 
underestimate the inhibition of neuronal differentiation 
caused by dex. The inhibitory effect of dex on NGF-in-
duced neuronal differentiation was more pronounced 
than in the case of bFGF, affecting both the rate and the 
extent of neurite outgrowth (Figure 10; Figure 2A, NGF, 
open symbols). 
To distinguish whether the neuronal differentiation 
caused by bFGF reflects the phenotypic conversion of 
chromaffin cells (as observed for NGF [Doupe et al. , 
19ll5a]) or the selection for preexisting process-bearing 
cells (the adrenal medulla contains a small proportion of 
ganglionic neurons [Anderson and Axel, 1985; Trojanow-
ski et al. , 1986]), the number of cel ls in each dish was 
measured as a function of time in bFGF. This experiment 
revealed that between days 2 and 6, the number of cells 
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Figure 2. Effects of bFGf and NGF on the Time Course of Neurite 
Outgrowth 
(A) Cells were counted and scored for the presence of ncuntcs. for 
each of the experimental conditions. the percentage of cells beM-
ing a process IS ploucd against the number of days in culture. In 
all panels, ftlled squares correspond to the presence of the factor 
mdicated in the upper left corner of the panel and open squares 
correspond to the factor in combination with 1.0 ~M dcx. Control 
indicales thJt cells were grown in growth medium alone; NGF mdi-
cates the presence of 1.0 11g/ml 75 NGF; FGF indicates the presence 
of 10.0 nglml bFGF. The values plotted are averages of several diSh.,.; 
for eo1ch condit1on on each day, obtained from two independent 
c>pcr~mcnts (days I and 2, n - 10; day 6, n - 6; day 10, n - 4). 
Error bars indicate the standard error of the mean. 
(B) Dose-response characteristics of bFGf.induced ncuntc out-
growth. Cells \VCre counted and scored as in (A). Each point 
represents the average value of counts from at least t'NO dishes with 
the exception of day 10, 0 .1 ng/ml and 1.0 ng/ml conditions (n -
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F1gure 3. Effects of l>FGF and NGF on Chrom.tfhn Cell Number 
for each of the cxpcriment<1l conditions, the percent mcrcase in the 
number of cells over day I (to normalize for initial differences 1n 
plating cffiC•encies) is plotted agamst the number of days in culture. 
In all panels, filled squares corr.,.;pond lo the pr.,.;ence of the factor 
indicated in the upper left corner of the p.lnel o:md open squares 
correspond to the factor 1n combination with 1.0 ~M dcx. Control 
mdicatcs that cells were grown 1n growth med1um alone; NGf tndl-
cates the presence of 1.0 11g/ml 75 NGF; rGr ind1catc<; the presence 
of 10.0 ng/ml bFGF. The values plotted arc averages of several diShes 
for CJch condition on each day, obiJincd from two independent 
experiments (days 1 and 2, n - 10; day &, n - 6; day 10, n - 4). 
Error bars indicate the standard error of the mean. 
in bFGF increased only sl ightly (Figu re 3, FGF, filled sym-
bols), whereas the percentage of process-bearing cells 
rose to over 80% during this same interval (Figure 2, FGF, 
filled symbols). It is therefore likely that bFGF, like NGF 
(Figure 2; Figure 3; Doupe et al., 1985a), acts by induc-
ing the phenotypic conversion of chromaffin cells to neu-
rons, rather than by selecting for preexisting neurons in 
the culture. This interpretation is supported by serial 
observations of identified chromaffin cells (described 
below)_ 
bFGF Is a Chromaffin Cell Mitogen 
In cultures exposed to bFGF, a striking increase in the 
frequency of ce ll clusters was observed. This raised the 
possibility that, in addit ion to stimulating neuronal dif-
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Figure 4 Effects of bFGF ,1nd NGF on the Incorporation of 
I'IIIThyrmcline rn Chromaffrn Cells 
Cells were grown for 6 dtlVS m the vanous culture cond1tions ~tnd 
then exposed to ( 1H}Ihymt<hne for 24 hr. Culturt.~ were pro-
cessed, ,1nd OX-7-postlivc cells were scored for the presencc of sii-
VN gr~1m~ over the nuclcL The pcrccnt.1gc of chrom~1rfin cells that 
mcorpor.1 tcd thymtdine was calcu lated. (A) Control tndicatcs th.:H 
cells were grown 1n growth medium alone; dex indtc.1tes the wcs-
en<c of 1.0 !IM dex; NGF rndrcatcs the presence of 1.0 !lg/ml 75 
NGF. NGF + dex indicates the both NGF and dex were present; 
FGF rndrcates the presence of 10.0 ng/ml bFGF; FGF + dex rndr· 
catC's th.1t both brGF and dcx were presC'nt in culture. The avcr.1gc 
of d.1ta from f111c dtshcs in each condttton is plotted. Error bars mdi-
c.lte thc standard error of the mean. (B) Dose-response for thymi-
dine incorporation. Data rt~prcsent the average from three rflshcs 
for each condition. Error bars mdicatc the standard error of the 
mc~1n 
maffin cells. Thi s possibi lity was also suggested by the 
prev1ous observ<llion th,lt NGF is a chromaffin cell mitO-
gen (ltllicn and Claude. 1985). [ 1H]thymidme labeling 
o f cu ltures on day 6 confirmed that bFGF. like NGr, 
Stimulated DNA synthesis about 3-fold in chromaffin 
cells (Figure 4A). The dose-response for mitogenic stim-
ulation con firmed that a concentratio n of 10 ng/ml was 
saturating for this effect (Figure 48). Although dex 
strongly inhibited the mttogenic action of NGF (as previ-
ously reported [Lillien and Claude, 1985]), it did not do 
so for bFGF (Figure 41\). This difference in the inhibitory 
effect of dex was further reflected in cell number mea-
surements: in bFGF plus dex, cell number increased sig-
nificantly by day 10 in culture (Figure 3, FGF, open sym-
bols), w hereas dex inhibited the increase in cell number 
caused by NGF (rigure 3, NGF. open symbols). 
bFGF Induces a Dependence on NGF but 
Docs Not Itself Promote Survival 
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r 1gurc 5. [ffect ofV.uyu1g bFGr Conccntr.Hion on Chromaffin Cell 
Surviva l 
The percent clccreasc m cell number at d~1y 10 relatiVl' to day 1 IS 
shown. Data for 3, 10, .1nd 30 ng/ml represent the average from two 
Sl~tcr cultures. while data for 0.1 ;md 1.0 ng/ml arc from (1 smglc 
culture; ~111 ~uc based on mitial counts of 350-400 cells per cuhurc 
on day 1. The apparent slight dccre,1se in cell loss at 0. 1 ng/ml bFGf 
m.1y not be statistically Significant. t lowevcr, at th is concentrat1on 
.1 significantly smaller proport1on of the cells were process-beanng 
(48% compMed with 95% for 10 ng/ml bfGF); therefore it is possr-
hle th.Jt ~11 low conccntrat1on!t bFGF m~1y 1m prove the viability of 
those chromJffin cells wh1ch have not yet converted to neurons 
maffin cells between days 2 and 6 in vitro, between days 
6 and 10 a significant difference was observed. 1n bFGF, 
the number of cells decreased precipitously during this 
later interval, while the cell number increased in NGF 
(Figure 3, filled symbols). One possible explanation for 
this difference is that bFGF can induce the neuronal dif-
ferent iation of chromaffin cells, but it cannot support 
their subsequent survival as sympathetic neurons. In 
support of this interpretation, cultures of neonatal sym-
pathetic neurons (derived from superior cervica l gan-
glia) cannot be maintained by bFGF (data not shown), 
consistent with the findings of Rydel and Greene (1987). 
Thus, although bFGF can support the surviva l o f some 
CNS neuronal populations (Wal icke et al., 1986; Morri-
son et al., 1986; Hatten et al., 1988), and even parasym-
pathetic periperal neurons (Unsicker et al., 1987), it 
does not do so for neonatal rat sympathetic neurons. 
In a ~epa rate experiment (Figure 5). it was derermined 
that varying the concentrat ion of bFGF over a wide 
range (0.1-30 ng/ml) did not significantly improve the 
viabil ity of cells when measured at day 10, by which 
t1me most have converted to a neuronal phenotype. In 
all concentrations of bFGF tested, a net cell loss oc-
cu rred, whereas in the experiment of Figure 3, a 60% in-
crease in cell number at day 10 was observed in the pres-
ence o f NGF. A lthough under con trol conditions (no 
added facto rs), the extent of cell loss at day 10 was simi-
lar to that seen in 10 ng/ml bFGF (Figure 3), the attrition 
in control cu ltures reflects the elimination of chromaffin 
ce lls, which are glucocort ico id-dependent (Figure 3, 
control versus dex); in contrast, the loss of cells in bFGF-
containing cultures occurs in a population expressing a 
neuronal phenotype. 
The simplest interpretation of the decline in cell num-
ber in bFGF after day 6 is that at about this time, the 
chromaffin-derived neurons have acquired an absolute 
A PolcniiJI ~ole for FCF in Sympalhellc Ot~velopm('nl 
Sll 
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" Cells were swnched to the mdicalcd t1c1or on d.1y 0 of culture 
hCell counts were made as for Figure 3. Values reflccl the average 
cell numbers obtained from at least two rl1shes for c~1ch condilion. 
Cells (200 400 1n c~1ch cltsh) were SLOrcd on d.ty 6. Thf' numh<·r 
of cells ttl ddy 10 •. lftcr sw11chmg from bfGF to NGf on day 6 w.t~ 
404 ± 59; 1n cultu res mamtamcd in NGf 11 w,1s 455 ± 115; 1n tho~e 
maml.uncd m bfGF 11 was 172 ± 213. 
1 Numbers b,u,cd on followmg ind1v1dual 1dent1f1cd cells .1s 
dcscnbcd rn the text. The mass cuhure dJta and the 1dcntified cell 
d.11,1 MC from two separate experiments 
dependence upon NGF, which cannot be substituted by 
bFGF. A prediction of this hypothesis is that NGF should 
rescue cells previously triggered to convert to sym-
pathetic neurons by exposure to bFGF. To test this 
prediction, ce lls were exposed to FGF for 6 days and 
then switc hed to medium containing NGF. This treat-
ment prevented the steep decline in cell number that 
ocurred after day 6 in bFGF, maintaining about 73% of 
the total number of cells maintained in control culture~ 
exposed only to NGF (Table 1, Mass Culture column). 
To exclude the poss1bility that bFGF and NGF may act 
on different subpopulations of chromaffin cells, in a sep-
arate experiment individual cells were identified during 
exposure to bFGF and then serially observed after switch-
mg to medium containing NGF. These experiments con-
firmed that most cells which had initially extended 
processes in response to bFGF died after day 6 when 
maintained in bFGF, as suggested by the cell counting 
data (Figure 6, FGF- FGF, days 8 and 12). In dramatic 
contrast, however, process-bearing cells in sister cultures 
survived when the medium was swi tched to NGF after 
day 6 (Figure 6, FGF- NGF, day 12). Of the identified 
cells, 92% survived when switched to NGF (n - 13). 
while only 16% su rvived when maintained in bFGF (n 
- 19) (1Jble 1, Identified Cell column). The rescued cell~ 
acquired the large cell bodies characteristic of cel ls main-
tained continuously in NGF (Figu re 6, NGF - NGF). 
These single-cell tracking data thus strongly support the 
idea that when ch romaffin cells are triggered to undergo 
neuronal differentiation by bFGF, they acquire a depen-
dence upon NGF for survival that is not salisfied by 
bFGF. 
The effects of the purified bovine pituitary bfGF prep-
aration reported here could be mimicked by a prepara-
tion of recombinant human bFGF at similar concentra-
tions (data not shown). As discussed previously elsewhere 
(Kimelman and Kirschner, 1987), this control makes it 
highly unlikely that the biological activities observed with 
the purified bovine preparation arc due to any molecule 
other than bFGF. Also, we observed a similar response 
to bFGF when chromaffin cells were plated on a simple 
111 
collagen substrate rather than Matrigel (data not shown). 
making it unlikely that the effects we observed in the lat-
ter case are due to a synergistic interaction (Kimelman 
and Kirschner, 1987) between bFGF and other growth 
factors which may be present in Matrigel (!-lynda Klein-
man, personal communica tion). 
Discussion 
aFGF and bFGF have mitogenic and/or differentiation-
inducing effects on a variel y of precursor cell types, in-
cluding myoblasts and chondroblasts (Linkhart et ill., 
1980; Kato and Gospodarowicz, 1985; for review, see 
Gospodarowicz et al., 1986b). It was found that bFGF 
exhibits both activities on cultured adrenal chromaffin 
cel ls, which function as stably differentiated endocrine 
cel ls in the adult o rganism. (A preliminary report indi-
cates that aFGF has similar effects [Claude et al., 1987, 
Soc. Ncurosci., abstract].) In this case, bFGF induces the 
transdifferentiation of chromaffin cells into sympathetic 
neurons, rather than the further differentiation of an en-
docrine phenotype. This effect, as well as the mitogen1c 
effects, is similar to the action of NGF on chromaffin 
cells (Doupe et al., 1985a; Lillien and Claude, 1985). 
Similarly, both NCr and bFGF cause PCI2 cells to ex-
tend neurites (Togari et al., 1985; Wagner and O'Amore, 
1986; Neufeld et al., 1987; Rydel and Greene, 1987; 
Schubert et a!., 1987) and to increase the expression on 
neuron-specific mRNAs (leonard et al., 1987; Stein et 
al., 1988a). The present work also reveals a difference 
between the actions of bFGF and NGF: bFGF cannot 
support the long-term su rvival of chromaffin cell -de-
rived neurons, while NGF can (Table 2). llowever, bFGr 
does induce a dependence on NGF for su rvival, perhaps 
as part of a program of neuronal differentiation that it 
triggers in chromaffin cel ls. 
The changes in the size of the chromaffin cell popula-
tion in response to NGF and bFGF (Figures 1-3) can be 
a,nalyzcd in Jerms of the contributions of cell division, 
surv1val, and death. The increase in total cell number in 
NGF (Figure 3) reflects the mitotic expansion of the 
differentiating population, as well as its subsequent ~ur­
vlval as neurons. I fowever, the proliferation effect is 
delayed, as indica ted by both [ 11-l]thymidine incorpora-
tion on day 2 (data not shown) and single-cell track ing 
analy~is (Figure 5). This delay in the mitogenic effect of 
NGF yields the flattened early portion of the growth 
curve (Figure 3). Since many cells extend neurites during 
this in terva l, this lag indicates that proliferation is not 
necessary for neuronal differentiation, consistent with 
the fact that neurite outgrowth from chromaffin cells can 
be observed in the presence of anti-mitotic agents 
(Ooupe eta!., 1985a). For bFGF, the decline in cell num-
ber after day 6 (Figure 3) reflects the fact that as these 
cells become neurons, they acquire a dependence on 
NGF for survival that is not satisfied by bFGF. In support 
of this interpretation, serial observations of ident ified 
cells revealed that NGF can rescue cells that have been 
triggered to undergo neuronal differentiatoon by bFGF 






FGF-+FGF . FGF-+NGF 
figure 6. Chrom.1ffin Cells Induced to Become Neurons by bFGF Arc Rescued by Trcotment with NGF 
ror c~1ch of these conduions, cells were photographed on the f.rs t day and on several subsequent days in cuhurc. for the NGF- NCr condi· 
tion, cells were maintained in 1.0 ~g/ml 75 NCr throughout the scrk-s. ror the fGF - FGF condition, cells were maintained in 10.0 ng/ml 
bfGF throughout the series. For the FGF- NGf condition, cells were inittally treated with FGF and then swttched on day 6 to medium 
containtng NCr instead of bFGF. The small triangles indicate ncurites emerging from the chromaffin cell clusters. The sm~11l <Hrows indicate 
the nuclei of some of the cells in the c lusters. The large arrowc; indic.11c cellular debris left where clusters once existed. B.u, 25 llm . 
~2jotent~<tl ~ole for FGF 1n Sympathetic Development 





NGF + dex 










the combina tion of bFGF and dex ca uses cell number 
to increase dramatical ly by d ay 10 (Figure 3). This differ-
ence can be explained by two different effects of the glu-
cocorticoid. In the presence o f dex, the neuronal differ-
entiation effect of bFGF is suppressed (Figure 1; Figure 
2). while the mitogenic effect is not (Figure 4). Thus, cells 
rema in in the chromaffin state and continue to prolifer-
ate. (As in the case fo r NGF, the mitogenic effect of bFGF 
is delayed.) 
NGF was originally c haracterized as a su rvival facto r 
for sympathetic neurons (levi-Montalcini, 1976). Gluco-
corticoids, on the other hand, have been shown to func-
tion in part as a survival factor for adrenal c hromaffin 
cells (Doupe et al., 1985a; Figure 3, compare contro l 
versus dex, day 10). In the absence of glucocorticoids, 
but in the presence of NGF, chromaffin cells survive and 
extend neurites. This initially suggesteci that NGF might 
substitute for dex as a chromaffin cel l survival factor, but 
that in the absence of the inhibitory influence of gluco-
cortico id (Unsicker et al., 1978), the endocr ine ce lls 
would undergo neuronal differentiation by default. The 
data presented here suggest a more complex mecha-
nism. In the absence of any added factors, c hromaffin 
ce lls survive for several days but do not undergo sponta-
neous neuronal differentiation . Therefore, the neuronal 
differentiation of chromaffin ce lls is not a default path-
way, but requires both the presence of an inducer (bFGF 
o r NGF) and the absence of an inhibitor (dex). The fact 
that bFGF can induce neurona l differentiation but is not 
suffic ient for subsequent survival suggests that the abil ity 
of NGF to induce neuronal differentiatio n may be dis-
tinct from its effects on survival (Doupe et al., 1985b; Pat-
terson, 1987). 
Developmental Implications of the Chromaffin 
Cell Response to FGF 
The similar but distinc t responses of chro maffi n ce lls to 
NGF and FGF (Table 2) imply that these two factors may 
activate different intracellular signaling pathways. The 
ex istence in ch romaffin cells of such alternative signal 
transduction cascades, producing overlapping but non-
identica l sets of biological responses, could be simply 
coinciden tal. Alternatively, if the response properties of 
chromaffin cells are similar to those of embryonic sym-
pathetic precursors, these properties would fit well w ith 
some of the spatial and tem poral constraints that recent 
data have placed on the embryonic development of sym-
pathetic neurons. For exa mple, NGF, which is synthe-
sized by targets of sympathetic innervation (Heumann et 
al., 1984; Shelton and Reichardt, 1984), is not produced 
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until the time at which embryonic neurons have grown 
axons to these targets (Davies et al., 1987; Korsching and 
Thoenen, 1988). Therefore, some other factor(s) may act 
at or near the forming ganglia to trigger the initial out-
growth o f axons from neuroblasts to the periphery. Our 
resu lts suggest that FGF, o r some other molecule exert-
ing identica l effects, could serve such a function in vivo. 
The intracellular signaling pathway acti vated by th is fac-
tor would not only initiate axon outgrowth, but would 
expand the population of ganglionic neuroblasts as well. 
The adrenal gland is also known to be a source of bFGF 
(Gospodarowicz et al., 1986a). and thus the established 
dex insensitivity of the mitotic response would allow the 
expansion of the developing medullary cell population 
wi thin the glucocorticoid-rich adrenal gland, while si-
multaneously preventing neuronal differentiation . 
In chromaffin cells, the FGF response pathway also 
leads to the acquisi tion of NGF dependence. By exten-
sion, in embryonic sympathetic precursors, the timing of 
this NGF-dependence m ight coincide with the arrival of 
sympathetic axons at their NGF-enriched peripheral tar-
gets. Simultaneously, the inability of the FGF signaling 
pathway ultimately to support neuronal survival would 
ensure the elimination of those neurons that failed to 
reach an appropriate peripheral source of NGF. Local 
NGF secretion by the target would then activate an alter-
native intracellular signaling pathway in sympathetic 
neurons, w hich would allow their subsequent survival 
and further maturation. In this way, a combination of 
factors, acting at different stages of development and trig-
gering overlapping but distinct response cascades, could 
control a crucia l sequence of steps in the early develop-
ment o f sympathetic neuro ns. 
Preliminary observations suggest that the response 
properties of chromaffin cells to bFGF and NGF may in-
deed reflect the response properties of embryonic sym-
pathet ic precursor cells. In particular, it has been ob-
served that bFGF stimulates neuronal differentiation in 
cultures of E14.5 paravertebral and superior cervica l 
sympathetic gangl ia (0. L. S. and ). Carnahan, unpub-
lished observations). Moreover, sympathetic neurons 
at this stage do not require NGF for survival in vitro 
(Coughlin and Collins, 1985). In addition, bFGF appears 
to be mitogenic for E 14.5 precursors in the presence of 
dex (A. Michelsohn, unpublished data). Thus, bFGF 
seems to induce a set of responses in embryonic sym-
pathetic precursors similar to those induced in neonatal 
chromaffin cells. Confirmation of such a role for b FGF 
in vivo, however, awaits the development of methods for 
the sensitive detection of FGF in the mammalian em-
bryo as well as the perturbation of its function. 
Experimental Procedures 
Cell Preparation 
The adrenal medullae of neonatal (1-3 days) Simonsen albino rats 
(Simonsen ~bora torics Inc., Gilroy, CA) were dissected free of cor-
tex in L-15 air medium (Hawrot and Patterson, 1979). The medullae 
were dissociated by a modification of the method of Unsicker et al. 
(1978) in Hank's buffered saline solution without CaH and MgH 
(GIBCO, Grand Island, NY) containing 1.0 mglml collagenase 
Neuron 
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(Worthington Diagnostics. freehold, NJ). Cell suspensions were 
centnfuged tw1ce at 1000 rpm for 10 min and resuspended mto 
groWih medium. To remove the more substrate~adherent cortical cell 
population, the cell suspension was preplated on 100 mm Corning 
tissue cultu re plates (Corning Class Works, Corning, NY) for b hr 
in growth medium in .1 hum1dlfied incubator at J7°C and 5~ C01 . 
The chromaffin cells were removed from the plates by gentle tritu ra~ 
tion, centrifuged at 1000 rpm for 10 min, resuspended into growth 
medium, and plated on p reviously prepared plates at a dens1ty of 
400-3000 cells per well. 
Culture Media 
The growth med1um used m this study WitS prepared as described 
by Mams and Patterson ( 1973; Hawrot and Patterson, 1979) and was 
supplemented with 5% adult rat serum and 5% fetal calf serum (Hy-
Cionc, logan, UT). To generate the various experimental media, the 
growth medium was supplemented w1th one or more of the follow~ 
ing additives: dexamethasone phosphate (Merck, Sharpe & Oohme, 
Teterboro, NJI at a final concentra tion of 1.0 11M, NGF (75) (Mains 
and Patterson, 1973) a t a final concentration o f 1.0 ~glml, or bovine 
bFGF, prepared according to Gospodarow1cz (1975), or rccombinanl 
human bFGF at a final concenlralion of 10 nglml. The bovine bFGF 
was a gift of Cera Neufeld, University of California, San Francisco, 
and the recombinant human bFCF was a gift of Forrest Fu ller, Cali-
fornia Biotechnology, Inc., Mountam View, CA. 
Culture Dishes and Substrate 
For the experiments in which the time course of process outgrowth 
was assayed, cells were growing on Aclar (Allied Chem1cal Corp., 
Mornstown, NJ) coverslips in 35 mm falcon petri dishes (Becton 
Dickinson and Company, Oxnard, CA) in which an 6 mm well had 
been lathed (H awrot and Patterson, 1979). The dishes were stcri· 
lized by UV irradiation. To prepare the substrate, dishes were 
cooled 10 4°C and coated with 50 111 of M,llrigel (CollaboraiiVC Re-
search, Bedford, MA}, an Engelbreth~ t tolm~Swarm scucoma extracel-
lula r mat rix (Hadley et al., 19851, mixed 1:1 with growth medium. 
After 10 mi n, the coated dishes were flooded with 2 ml of e'peri-
mental media and left for 1 hr at 4°C to allOW' the substrate meniscus 
to flanen. They were then transferred to a 37•C incuba1or for at 
le.1st 1 hr to induce substrate polymenzallon and equilibration with 
the 5% C02• After 1 day in culture, the cells were overlaid with 
Mat rigel mixture as follows. The medium and dishes were chilled 
to 4°C. Most of the medium in the d1shes was drawn off, and .1n 
additional 50 J.t l of the Matrigel mixture was spread over the cells. 
The dishes were then flooded with cold medium ,1nd returned to 
the incubator, where they were maintained throughout the experi-
ment. Cultures were fed every 4 days. 
For (1H)thymidme incorporation expenments, 15 x 3 mm glass 
rings (Thomas Scientific, Swedesboro, NJ) were attached to the bot~ 
toms of 35 mm Corning tissue culture dishes with high-vacuum sili~ 
cone grease (Dow Corning, Midland, Mil. The bon oms of I he wells 
formed by the glf'ISS rings were coated w1th 100 ~I of Matngel mix-
ture as described f'lbove. 
For identified cell studies, a BB-Press petri dish press (World Pre-
cision Instruments, Inc., NC"N Haven, CT) was used to imprint a grid 
pattern on the bottoms of 35 mm Cornmg tissue culture d1shcs. 
Class rings were attached to t he dishes outside the grid pattern as 
described above. 
Cell Counting 
For the 11me course of process outgrowth studies, chromaf[m cells 
were distinguished on the basis of their phase~dcnse granui.Jr 
cytoplasm under phase·contrast optics at a total magnification of 
200x. A cell was counted as bearing a process if the process cx-
lendcd >3 cell body diameters from the soma. Where cells were 
clustered, the number of nuclei was recorded as the total number 
of cells, and the number o( emerging processes was recorded as the 
number of process~bearing cells. Cell numbers were measured by 
counting all of the cells in two parallel strips constituting ~30% of 
the total growth surface area. In this way, from 100 to 600 cells were 
scored for each dish, depending upon t1me and condition. 
114 
(1 H]Thymidinc labeling 
At day 6 after plating cultures were exposed to l'H )thym1dinc (ICN 
Radiochemicals, Irvine, CAl at ~1 final concentration of 2 ~Ci/ml for 
24 hr. Cultures were rinsed with PBS and fixed with 3.7% forma Ide· 
hyde in PBS. The cultures werp then mcubated w 1th OX·7, an anti· 
Thy-1 monoclon~• l ~1nt1body, .1nd c;traincd with .111 FITC-conjug~1tcd 
goat anti~mouse lgG secondary antibody (TACO, Burlingame, CAl 
10 label specifically the chromaffin cells in the cultures. The OX-7 
hybridom.1 cell line was a gift of Alan Williams, MRC Cellular Immu-
nology Umt, Oxford University. The labeled cultures were coated 
wuh photogr.1phic emulsion, Kod.1k NTB2 (E.lstman Kocl.1k Com· 
pany, Rochl•stcr, NY), d iluted 1:1 in 0.5 M socl1um ~'cct ;uc •• 1nd ex· 
posed for 7 days at 4"C. The dishes were developed w1th Kod,lk 
D -19 devl'lo1>Cr and scored. OX-7~positivc cells wcore counted w1th 
epifluorcscencc illumination, and those cells that had Incorporated 
( 111)thymidine were scored under bright·ficld Illumination. All posi~ 
tive cells in all cultures were counted at a final magmfication of 
200 X. 
Identified Cells 
Cells were identified by means of a gridded cilsh ,1nd pho10graphed 
w11h 35 mm Plus-X film at ASA-125 under phase-contrast oplics al 
a final m.JgnifJCation of 400x. for several days after imt1al plating, 
the same fields were photographed. 
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Kt•yu·ord<: Schwarm cell: NGF receplor: 217c; 192-lgG: R/\N-1 
Monoclonal ant1body 217c was generated against an ~•ntigcn expressed on the rat glial cell line. C6 glioma. 217c has been shown to recognize 
Schwarm cells m mixed cultures as well as in tissue sections and has been used to 1dcntify Schwann cells independent of other markers. such as 
monoclonal anlrbody 192-lgG, whrch rccogmzes rhc rat low aninity nerve growlh faclor (NGF) rcccplor. Here we show thai the anligen recognized 
by 217c is I he rat low-aninily NGF reccplor. This indica res rhal monoclonal antibodies 192-lgG and 217c arc nor indepcndenl markers and lherefore 
I hal addirional criteria need lobe used for I he identification ofSchwann cells early in dcvclopmcnl. 
Antigenic markers that are expressed on the cell sur-
face provide a powerful means to identify and isolate 
subpopulations of cells in a non-destructive way. With 
such a marker one may purify populations of cells and. 
for example. study their developmental potential. or 
growth factor and hormone responsiveness, in the ab-
sence of activities that may be contributed by other cell 
types. One can also usc the marker to identify individual 
cells in mixed populations and to establish progenitor-
progeny relationships. as has been carried out for glia 
derived from the 02-A progenitor in cultures of optic 
nerve [13]. 
With the aim of identifying cell-surface markers useful 
for the study of early Schwann cell development, we 
screened tissue sections of early rat embryos and cultures 
of neural crest with antibodies that had been previously 
characterized as independent Schwann cell markers. 
Among the antibodies tested were the monoclonal anti-
NG F receptor antibody 192-IgG [3] and the monoclonal 
antibody 217c. 217c is thought to recognize the RAN-I 
antigen [I, 5] and has been utilized as an independent 
Schwann cell marker [14, 15]. Recently, Jessen ct al. [8] 
have shown that the 217c antigen is selectively expressed 
by non-myelin-forming Schwann cells in adult rats, but 
is expressed by essentially all Schwann cells earlier in de-
velopment. We found that 192-lgG and 217c labeled 
Corrc.<pondcnce. D.L. Slcmplc, Division of Biology 216·76, Howard 
Hughes Medical lnslilulc. California lnslilulc of Technology. Pasa-
dena. Cl\ 91125. U.S.A. 
very similar subsets of cells in the embryo including spi-
nal cord motorncurons, cells of the dorsal root and sym-
pathetic ganglia, and cells associated with the ventral 
roots of the spinal cord (Fig. I). The coincidence of 
NG F receptor and 217c immunoreactivity suggested 
that 217c also recognized the NG F receptor. 
To test whether 217c and 192-lgG recognize the same 
molecule two experiments were performed. In the first 
experiment, NG F receptors of PC 12 cells were chemi-
cally cross-linked with iodinated 2.5S NGF as described 
[6]. Detergent extracts from these cells were immunoprc-
cipitated with antibodies 2 17c, I 92-IgG and, as a control 
ASCS4, a monoclonal antibody that recognizes another 
PCI2 surface antigen N ILE/LI / NgCAM [16]. Both anti-
bodies 2 I 7c and 192-lgG precipitated a labeled protein 
complex of identical size, which was not brought down 
by ASCS4 (Fig. 2). The molecular weight of this com-
plex, - 103 kDa, is appropriate for the NGF/ Iow-affi-
nity NGF receptor cross-linked product [7]. These re-
sults arc similar to those recently obtained independently 
by Kumar et al. [9] in C6 glioma cells. While these immu-
nochcmical results strongly suggest that 217c recognizes 
the rat NGF receptor. they do not formally exclude the 
possibility that the antibody recognizes only a complex 
between NGF and its receptor. or another protein asso-
ciated in detergent extracts with the NGF-NGF receptor 
complex which is not itself the receptor. 
To prove that both 192-IgG and 217c recognize the 
low-affinity NGF receptor, an independent genetic 
experiment was performed. A stably-transfcctcd mouse 
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Fig. I. Adjacent trunk sections of embryonic day 12 rat stained with 
192-lgG (A) and 217c (D). Scale bar is 100 pm. 
L-ccll line carrying a rat NGF receptor eDNA [2) was 
compared with the untransfectcd parental cell line by 
immunofluorescence staining and flow cytometry, with 
both 217c and 192-IgG. The transfccted cell line 
(LpMVR) was stai ned by both 217c and 192-IgG, but 
the untransfccted line Ltk- was not stained by either 
antibody (Fig. 3). Because both 2 17c and 192-lgG arc 
specific to rat NGF receptor (not shown) and Ltk- is a 
mouse cell line, this result cannot be explained by the 
induction o f the endogenous NGF receptor gene, or in-
deed of any other associated endogenous mouse pro-
duct , in the transfcctcd cell line. 
We demonstrate here that both 217c and 192-lgG 
immunoprecipitatc an NGF-NGF receptor complex, 
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Fig. 2. An autoradiogram of a polyacrylamide gel showing the immu-
noprecipitation of "'1-NGF cross-linked to its recepto r using 192-lgG 
(lane A). 217c (lane B). and ASCS-4 (lane C). Equal amounts of lysate 
and antibody were used in each reaction. 
fee ted with ra t NG F receptor eDNA is immunoreactive 
with both antibodies whereas the parental cell line is not. 
We conclude. therefore, that both 2 17c and 192-lgG rec-
ognize the low-affinity subunit of the rat NGF receptor. 
It is necessary, however, to reconcile the conclusion of 
this study with previous reports showing that the im-
munoprecipitable products of 192-IgG and 217c have 
different molecular weights. Specifically. when 217c is 
used to immunoprecipitate 1251 labeled membrane pro-
teins from C6 glioma, a -64 kDa product is observed 
[10) ; when 192-IgG is used to precipitate 1251 labeled 
membrane proteins from PCI2, an -83 kDa product is 
found (12). The discrepancy between the published mole-
cu lar weights may be explained in one of several ways. 
One possibility is that the immunoprecipitated products 
of 217c and 192-IgG may be glycosylatcd to different 
extents. Radcke et at. have suggested that extensive gly-
cosylatio n may explain the difference between the 
observed -83 kDa protein and the -42 kDa polypep-
tide predicted from the sequence of NGF receptor 
eDNA. Another explanation may be that the NGF 
Fig. 3. Untransfectcd mouse Ltk- cells (Panels A and C)' and a stable line of Ltk- cells transfectcd with rat NGF recepto r eDNA. LpMVR cells 
(Panels Band D) stained with antibody 192-lgG (Panels A and D) and 2 17c (Panels C and D). The left frame in each panel shows the pro file from 
cells analyzed by now cytometry: cell number is plotted on the o rdinate: relative nuorcsccncc in arbitrary un its is plotted o n the abscissa. The midd le 
and right frames of each panel are phase contrast and nuorescencc micrographs, respectively. of representative fields from dishes o f stained cells. 
The heterogeneity o f staining as seen by immunonuorcsccncc rcnccts a broad distribution of levels of expression of the transfected gene in the cell 
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receptor, even as recognized by 192-lgG, exists in mul-
tiple molecular weight forms [4]. In addition to the -83 
k Da form, a -50 kDa form has been detected in the cul-
ture medium of a rat schwannoma cell line, and a -77 
kDa form has been detected in plasma during early de-
velopment. The biochemical basis for the relationship 
between these different forms is not yet clear. 
The work described here was initiated to identify 
markers for embryonic Schwann cells. In the past 217c 
and the NGF receptor have been used as independent 
markers for Schwann cells [14, 15]. This study indicates 
that they arc not independent markers. Thus, additional 
criteria need to be applied to distinguish Schwann cells 
from other cell types early in their development. 
The authors would like to express their gratitude to Mo-
ses V. Chao for providing the LpMVR and Ltk-ccll 
lines, to Jean de Vcllis for providing the 217e antibody, 
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Mammalian neural crest stem cells 
The experiments described in chapter 2 were designed to distinguish two 
possible explanations for both the heterogeneity of primary neural crest cell clones and 
the observed multipotency in some of those clones. The two extreme models described 
in the introduction make distinct predictions about the outcome of the sub-cloning of a 
multi potent neural crest cell clone. For example, under the restrictive model one would 
expect none of the sub-clones to contain all of the differentiated phenotypes of the 
original clone. On the other hand under a stem cell model one would expect to find at 
least one sub-clone containing all of the phenotypes found in the original clone. That 
is, the key difference between the two models is that, if there is a stem cell, the 
multipotent cell will self-renew. No published experiments to date have specifically 
examined self-renewal of multipotency in the neural crest. 
In our studies, a majority of primary rat neural crest cell clones, produce a 
mixture of differentiated cells including peripheral neurons and Schwann cells. We 
also find that some primary clones appear to be founded by relatively restricted cells 
and produce clones that contain no neurons. When multi potent clones are sub-cloned, 
we find that many of the sub-clones are also multi potent and can produce that same 
range of measurable phenotypes as the original founder clone. In addition, we find 
some clones that are comprised of a single phenotype as well as some multipotent sub-
clones that do not produce the full range of phenotypes displayed by the original clone. 
Hence, a significant proportion of primary neural crest cells are both multi potent and 
capable of self-renewal. Furthermore, the fact that some of the sub-clones are 
comprised of only a single phenotype or a subset of the phenotypes available to the 
original founder clone indicates that some of the cell divisions of stem cells in the 
founder clone are asymmetric. 
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Our data establish the existence of a stem cell capable of producing neurons, 
glia and probably other neural crest derivatives. The data also establish some of the 
properties of neural crest stem cells and their derivatives at various stages of 
development. We also know that cell fate choices are being made within developing 
clones. Are those choices being made by an internal cellular program or are they 
controlled by external signals? If by an internal program, is it a deterministic or 
stochastic program? If by an external signal, do those signals cause the cell to become 
determined for some particular lineage or do they signal some general information, such 
as "divide," "survive" or "differentiate"? A few studies have been done that indicate 
that environmental signals can control the composition of clones derived from 
multipotent founder cells. 
In cultures of rat neural crest cells we have obtained evidence that environmental 
factors can act directly on founder cells to direct the fate of clones. Specifically, we 
find that clones grown fibronectin fail to generate neurons. The clones contain only 
Schwann cells and another unidentified cell type. When clones are grown on poly-D-
Lysine and fibronectin, however, they generate peripheral neurons, in addition to 
Schwann cells and the other cell type. We have carried the analysis further with two 
other experiments. In the first experiment we start with two sets of identified founder 
cells on a fibronectin substrate. We then apply pOL to one group of founders as an 
overlay, and allow both groups to grow and differentiate. We find that, with a high 
cloning efficiency of- 90%, that the pDL treated founders produce clones containing 
neurons, whereas, the clones grown on fibronectin alone do not. In a second 
experiment, a group of clones is initially grown on a fibronectin substrate. Each clone 
is then split into two different dishes, one dish is coated with fibronectin and the other 
is coated with pDL and fibronectin. Sub-clones are allowed to grow and mature and 
then analyzed. We find that most of the original founder clones produced neurogenic 
sub-clones when grown on pDL/FN but not on FN. Hence, even though clones do not 
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form neurons when grown on FN they retain neurogenic potential and can produce 
neurons when sub-cloned onto pDL/FN. On FN it is not the case that neurons or 
neuroblasts appear and then die for lack of trophic support or an adhesive substrate. 
Instead FN appears to promote dispersion of the cells in a clone. On pDL/FN, close 
cell-cell contacts are maintained. Furthermore, when neural crest cells are plated at 
clonal density on tissue culture plastic rather than FN or pDL/FN neurons are produced 
by the resulting clones. These data rule out selection as a mechanism to explain the 
effect of the substrate on the fate of clones. These results argue strongly that control 
over some cell fate choices derives from the environment in which stem cell and their 
progeny development. In this example, multipotent neural crest cells when grown on 
pDLIFN produce neurons but their neurogenic potential is not realized on FN alone. 
Hence, neural crest cells do not appear to develop by some set internal program. 
Instead they seem to be controlled directly by environmental factors. 
We have demonstrated that primary mammalian neural crest cells can self-
renew, but do they self-renew in the animal. It is possible that the conditions of culture 
lead to self-renewal, even though it does not happen in vivo. Consider the example of 
the development of neocortical laminae. McConnell and Kaznowski have found that 
the fate of neurons produced by a multi potent progenitor is specified at a particular 
point in the cell cycle by the local environment (McConnell and Kaznowski, 1991). 
Normally as the animal matures the environment of the progenitor cells is changing, 
and that change is uni-directional with respect to the neuronal fates that can be 
specified. As I argued in the introduction they have not demonstrated self-renewal of 
the multi potent cortical progenitor. But if one were to back-transplant postnatal 
progenitor cells to the E29 environment and self-renewal were observed, that observed 
self-renewal may be artifactual in the sense that it would never normally occur. Such 
may be the case for cultures of primary neural crest cells. 
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There are several approaches that might be taken to address the possibility that 
self renewal does normally occur during the development of neural crest derived 
structures. As Fraser and Bronner-Fraser have shown, it is possible to label single 
migrating neural crest cells (Bronner-Fraser and Fraser, 1988; Bronner-Fraser and 
Fraser, 1989; Fraser and Bronner-Fraser, 1991). If one were to label single cells as 
they have (with lysinated rhodamine dextran), allow the cells to divide once, and then 
with a distinct marker (e.g., lysinated fluorescine dextran) mark one of the two 
daughters, one may find that the daughters have equivalent and extensive 
developmental potentials. That is the parent cell has undergone self-renewal, at least 
with respect to the fates manifest by the progeny of the daughter cells. Such an 
experiment, however, can only reveal the fate of the cells not necessarily the 
developmental potential. Another approach is to ask; do neural crest stem cells, as we 
have defined them in chapter 2, exist in developing neural crest derived structures? For 
example, can one dissect out an E14.5 rat adrenal gland, dorsal root ganglion, 
sympathetic ganglion, sciatic nerve or enteric ganglion and find LNGFR+, nestin+ cells 
that are multipotent (forming neurons, glia and other) and exhibit self-renewal? 
While the cell we have described is clearly a stem cell for the production of 
neurons, glia and the other cell type, it is not clear if that cell is a totipotent neural crest 
progenitor or some intermediate cell type, restricted to the production of only a proper 
subset of all possible neural crest derivatives. We never observed the production of 
melanocytes for example. Other normal neural crest derivatives might be produced by 
the cell, but we lack either the markers to detect them or the culture conditions to 
produce them. Before an extensive survey of culture conditions is carried out it may be 
appropriate to challenge the stem cell to an environment where the appropriate signals 
are know to exist, i.e., a whole embryo as a transplant host or perhaps a slice of an 
embryo in culture. 
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Sympathoadrenal lineage 
Our goal was to test whether bFGF could act on primary adrenal chromaffin 
cells as it had been shown to for PC12 cells. We found that bFGF acts as a neuronal 
differentiation factor, a mitogen and can induce NGF dependence in neonatal 
chromaffin cells. FGF cannot act as a trophic factor for sympathetic neurons. During 
the normal development of the sympathetic ganglion NGF is not present in the ganglion 
at the time of neuronal differentiation, but is supplied by the peripheral targets of 
innervation at a later time. We then proposed that perhaps FGF or something like FGF 
acts in the developing ganglion to control neuronal differentiation. Since the 
publication of the effects of FGF on chromaffin cells there have been several reports 
published that have some bearing on our hypothesis. 
Birren and Anderson produced a cell line by immortalizing embryonic adrenal 
derived sympathoadrenal progenitors. They found that the cell is not responsive to 
NGF but responds dramatically to FGF by extending neurites and undergoing neuronal 
differentiation, including the induction of low affinity NGF receptor expression. A 
variety of other purified polypeptide growth factors were tested, and none except FGF 
caused the cell line to undergo neuronal differentiation (Birren and Anderson, 1990). 
In addition Birren and Augsburger have found that primary E14.5 HNK-1 +, B2-
adrenal cells respond to FGF by undergoing neuronal differentiation and a small 
minority of those cells eventually become NGF responsive, forming mature 
sympathetic neurons (Dr. Susan Birren and Adela Augsburger, unpublished 
observations). FGF has been detected in developing sympathetic ganglia by 
immunocytochemistry (Kalcheim and Neufeld, 1990) and by PCR amplification of 
ganglion derived eDNA (Derek Stemple, unpublished observations). 
It seems clear that FGF is present at the right time and place to induce neuronal 
differentiation but the issue will not be resolved until a direct test of the activity in a 
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developing ganglion can be performed. Several possible approaches exist for such a 
test. It may be possible to find a reagent, such a a blocking antibody, or antisense 
oligodeoxynucleotide, that can disrupt the activity ofFGF specifically, and apply the 
reagent to a developing ganglion in vivo or to an in vitro embryonic slice preparation. 
The other possibility is to perturb the activity of the receptor. It may be possible to 
construct a transgenic mouse that expresses a dominant negative form of the FGF 
receptor (Amaya et al., 1991) under the control of a sympathoadrenal specific promoter 
such as the Dl3H promoter (Mercer et al. , 1991). Such a construct would lack FGF 
receptor activity in the sympathoadrenal progenitor and the simple hypothesis would be 
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APPENDIX 1: Environmental control of neural crest cell fate in vitro 
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Abstract 
Previous clonal studies of neural crest cells revealed that the population is 
heterogeneous with respect to developmental potential. We have studied the 
development of mammalian neural crest cell clones in vitro and provide evidence for the 
progressive restriction of neural crest cell developmental potential under certain 
environmental conditions. We find that multipotent clones can produce progeny that 
are apparently committed to the production of only a single lineage. These results may 
serve to explain the observed heterogeneity of primary clones. In addition, the 
observed heterogeneity may be in part controlled by the environment in which the 
neural crest cells are grown. We find that the fate of primary neural crest cell clones is 
affected by the presence of serum in the culture medium. The serum responsiveness of 
neural crest cells or their progeny differ over time in culture. Clones founded at 24 
hours by LNGFR+ neural crest cells respond to FBS by extinguishing LNGFR 
expression. If neural crest cells are allowed to develop in serum-free medium for a 
period of time before clonal culture many of the clones are no longer sensitive to FBS 
and divide to form large LNGFR+ clones. The differential responses of clone 
founders provide an assay for phenotypic differences between them that are not 
apparent by morphological or immunocytochemical assays. 
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Introduction 
We have focused our study of neural crest cell development on the capacity of 
single early neural crest cells to produce differentiated progeny. In previous work the 
heterogeneity with respect to the ultimate phenotype of neural crest cell clones was 
highlighted as a key feature of the population of founders (Baroffio et al., 1988; Dupin 
et al., 1990). That is, although a large percentage of the clones were multipotent, 
different clones produced different subsets of the available lineages. Relatively few 
clones produced all of the available phenotypes and some clones appeared to arise from 
committed progenitors and were comprised of differentiated cells of only one or a few 
phenotypes. There are several ways that such heterogeneity might arise. One 
possibility is that the heterogeneity may be programmed into the population of neural 
crest cells before or as they emerge from the neural tube. Another possibility is that 
members of a relatively homogeneous population of clone founders are caused to 
manifest a restricted developmental potential by some extrinsic (e.g., 
microenvironmental cue) or intrinsic (e.g., stochastic) signal. Finally, it may be 
possible that emerging crest cells are homogeneous in their developmental potential but 
that since they are an actively dividing population they are in the process of producing 
progeny that have been specified to a relatively restricted set of fates. Chapter 2 
described sub-cloning experiments in which multipotent primary clones produced a 
mixture of secondary clone founders. Specifically we found that primary multipotent 
clones produced progeny that, upon subcloning, were found to be of a variety of 
phenotypes. Some multipotent subclones contained neuron ("N"), glia ("G") and 
another unidentified cell type ("0"). Other subclones contained subsets of those 
differentiated phenotypes, e.g. N-only, G+O and 0-only clones. These results, 
therefore, allow for the possibility that the observed heterogeneity of primary clones 
arises by the production of relatively restricted progeny of multi potent cells. In this 
chapter we examine the heterogeneity of neural crest cell clones in a culture condition 
133 
that allows the formation of a subset of phenotypes described in chapter 2. Neural crest 
cell clones grown on fibronectin (FN) contain only glial (G) and other (0) cells. We 
fmd that the majority of early (i.e. , 24 hour old) LNGFR+ founders produce clones of 
a mixture ofLNGFR+ and LNGFR- cells; whereas older (i.e. , 8 day old) LNGFR+ 
founders produce a majority of clones comprised entirely of LNGFR +cells. 
The observation that heterogeneity arises within multi potent clones presents 
another problem. How is the production of relatively restricted and differentiated 
progeny controlled within the spatially restricted environment of a clone? There is a 
substantial amount of evidence indicating that the fate of neural crest cells is controlled 
by the environment in which they develop (Le Douarin, 1982). And a fair number of 
studies that implicate specific growth factors or culture conditions in the control of 
neural crest cell fate (Satoh and Ide, 1987; Barald, 1989; Maxwell and Forbes, 1990; 
Morrison-Graham et al., 1990; Murphy et al. , 1991; Sieber-Blum, 1991) (see also 
review, Sieber-Blum, 1990). In Chapter 2 we presented evidence that the composition 
of the substrate can substantially alter the fate of neural crest cell clones in an instructive 
fashion. In this chapter we present evidence that the formation of 0 cells may be 
controlled by the presence of serum in the culture medium. The serum seems also to 




Primary neural crest cell undergo progressive restriction in developmental potential 
Colony analysis 
We sought to test the notion that over time in culture the developmental potential 
of neural crest cells becomes restricted. We reasoned that cells taken from early neural 
crest cultures would be predominately multi potent and that over time in culture they 
would prcxluce relatively restricted or committed offspring. In these experiments we 
limited our analysis to neural crest cells expressing low-affinity nerve growth factor 
receptor (LNGFR), a population we have shown to be capable of producing several 
identifiable neural crest derivatives (Chapter 2). As shown in Figure lA colonies of 
early (24 hour) or late (day 8) founders were examined. Example micrographs of the 
resulting colony types "LNGFR+" (i.e., all cells in the colony express LNGFR) and 
"mixed" (i.e., the colony is a mixture ofLNGFR+ and LNGFR- cells) are shown in 
figure 2. Considering only colonies that contain any LNGFR expressing cells, we 
found that colonies resulting from cells plated at day I were predominately of the 
"mixed" type (of the total number of colonies 7 .5 ± 2.5% were "mixed" and< 2% 
were "LNGFR+")(Figure 1 B). In sharp contrast, colonies resulting from cells plated at 
day 7 (whether analyzed at day 14 or at day 22) were predominately of the "LNGFR+" 
type (11% "LNGFR+" vs 5% "mixed" for day 14; and 18% "LNGFR+" vs 10% 
"mixed" for day 21). Over time in mass culture, a population of cells develop that are 
apparently committed to the production of only LNGFR+ cells. This population of 
cells develops from a starting population that is apparently not committed and can 
produce both LNGFR+ and LNGFR- cells. 
Serial subcloning analysis 
One interpretation of the results of the preceding experiment is that primary 
neural crest cell founders are multipotent and as they grow, they give rise to progeny 
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Figure 1. Neural crest cell colony analysis. 
A. This is a schematic outline of the colony analysis. Initially neural crest cell 
were plated either at clonal density or in mass cultures. Dishes plated at clonal density 
were allowed to grow in culture for an additional 13 days, at which time they were 
fixed and analyzed for LNGFR expression. The cells grown in mass culture were 
replated at clonal density at day 8 and allowed to grow for an additional 6 days, or an 
additional 14 days, after which the resulting colonies were fixed and analyzed for 
LNGFR expression. Colonies were assayed by examining them with a fluorescence 
microscope. 
B. LNGFR+ colonies in which either all of the cells expressed LNGFR 
(striped bars) or only some of the cells expressed LNGFR (stippled bars) are presented 
as a percentage of the total number (#) of colonies in each 100 mm dish. At least 3 
dishes per condition were analyzed. In this analysis, the phenotype of the founder was 
not determined at the time of plating. In fact the majority of founders are of the 
LNGFR- phenotype which in tum produce only LNGFR- colonies. This accounts for 
the relatively low percentage of LNGFR expressing colonies. 
A. 
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that are relatively restricted in their developmental potential, perhaps restricted to the 
extent that they are committed to produce only one differentiated phenotype. In the 
preceding experiment, founder cells were plated at clonal density, but colony founders 
were not screened to ensure that they were only single cells. This is a problem for 
analysis of "mixed" colonies since a "mixed" colony may have been founded by more 
than one cell and not a single multi potent cell. Furthermore, the phenotype of founders 
with respect to LNGFR expression was not determined. This is a problem because the 
relative number of LNGFR + and LNGFR- founder cells is variable between 
preparations of neural crest cells due to the variable amounts of LNGFR- non-crest 
cells. To ensure that "mixed" colonies indeed arise from single cells, and to test 
directly the hypothesis that founders of "mixed" colonies can produce "LNGFR+" 
clone (i.e., apparently committed) founders, we executed a serial sub-cloning analysis 
ofLNGFR+ primary neural crest cells. 
Neural crest cells taken from 24 hour neural tube explants were plated at a 
density of -225 cells I 100 mm dish. After the cells attached, individual LNGFR+ 
neural crest cells were identified and inscribed with a -3 mm circle drawn on the bottom 
of the dish. The circles were generally large enough to permit the unambiguous 
identification of the progeny of the cell at any time during the experiment. After 7 days 
in clonal culture the primary clone were scored for the continued expression of 
LNGFR. No LNGFR- founder was ever found to produce an "LNGFR+" or "mixed" 
clone. Among the LNGFR+ founders 20 ± 8% produced "LNGFR+" clones and 50± 
8% produced "mixed" clones. A substantial percentage of the LNGFR+ founders, 22 
± 10%, gave rise to clones containing no LNGFR+ cells; and 8 ± 2% of the LNGFR+ 
founders did not produce clones (Figure 3A). 
Analysis of primary clones at day 7 was done by live-labeling with LNGFR 
antibody, this allowed us to subclone some of the primary clones to test whether 
"mixed" primary clones contained precursors apparently committed to produce 
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Figure 2. Quantification of primary and secondary neural crest cell clones. 
A. Primary clones founded by LNGFR+ crest cells were analyzed for their 
expression of LNGFR after 7 days in culture. "LNGFR+" indicates that all of the cells 
of the clone expressed LNGFR. "Mixed" indicates that both LNGFR+ and LNGFR-
cells were in the clone. "LNGFR-" clones contained no LNGFR expressing cells. 
"Dead" indicates that no clone was formed. Values are presented as the percentage of 
the total number of founders ± s.e.m. 
B. Secondary clones founded by LNGFR+ cells derived either from "mixed" 
primary clones (hatched bars) or from primary clones containing only LNGFR+ cells 







































Figure 3. Serial sub-cloning of a "mixed" primary clone. 
Micrographs of a primary clone (A, B) and three of its progeny secondary sub-
clones are shown. The primary clone produce a "mixed" secondary clone (C,D), an 
"LNGFR+" (i.e., containing only LNGFR+ cells) secondary clone (E,F) and an 
"LNGFR-" (i.e., containing only LNGFR- cells) secondary clone (G,H). LNGFR 
immunofluorescence is shown in B, D, F and H. The corresponding phase contrast 
images are shown in A, C, E, and G. 
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"LNGFR+" clones. In this experiment "mixed" and "LNGFR+" clones were replated 
at clonal density on day 7. As for the primary founders, individual LNGFR+ 
secondary founders were identified and inscribed with a circle for subsequent 
identification. Secondary clones were allowed to grow for an additional 6 days and 
then were analyzed for LNGFR expression. As shown in figure 3B both "mixed" and 
"pure" primary clones produced both "mixed" and "pure" secondary clones. 
Proportionally more "pure" secondary clones were produced by the "pure" primary 
clones. Proportionally more "dead" clones resulted from subcloning "mixed" clones 
than from "pure" clones. LNGFR- secondary founders from "mixed" primary clones 
either produced no clone or gave rise only to LNGFR- cells. Hence some of the 
phenotypic heterogeneity observed among primary clone may be explained by 
multipotent founder cells producing offspring apparently committed to the production 
of a single phenotype. 
The fact that some secondary clones of pure LNGFR+ were of the "mixed" 
phenotype suggest that perhaps the expression of LNGFR is not a stable trait and calls 
into question whether "mixed" clones give rise to truly "pure" clones. It may be that, 
given enough time in culture, those "pure" secondary clones would eventually produce 
LNGFR- cells. In a preliminary experiment to address this problem we sub-cloned 
secondary "pure" clones. We found that most of the secondary "pure" clones gave rise 
only to LNGFR+ cells but that the continued proliferation of those cells required the 
presence of FBS, forskolin and either glial growth factor (GGF) or basic fibroblast 
growth factor (bFGF) (not shown). Subsequently those tertiary clones produced 
mature Schwann cells expressing glial fibrillary acidic protein (GFAP) and the sulfatide 
antigen recognized by the antibody 04 (not shown). 
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Primary neural crest cells are sensitive to FBS 
Although the LNGFR+ cells taken at different points in the culture period are 
morphological and immunocytochemically indistinguishable, they may represent 
several cell types distinguishable by other functional properties. For example, both the 
primary neural crest cell and mature Schwann or satellite cells express LNGFR and 
nestin and have a similar morphology, but we found that the primary neural crest cells 
eventually lose LNGFR expression in the presence ofFBS. Schwann cells grow well 
in FBS and may actually require some FBS components to divide in culture. In 
addition the observation that "pure" primary clones can produce secondary "mixed" 
clones coupled with the observation from the colony analysis that the probability of a 
founder to produce a "pure" clone increases over time in culture, suggests that there 
may exist more that one LNGFR +cell type in neural crest cultures. 
In our initial attempts to grow LNGFR+ neural crest cells we found that while 
neural crest cells could grow to produce large clones in the presence of FBS they soon 
lost expression of LNGFR. Moreover, we found that LNGFR- clones failed to 
produce either Schwann cells or neurons. One possibility to explain the loss of 
LNGR+ cells is that the FBS is somehow toxic to LNGFR+ cells and simply eliminates 
them. Another possibility is that the FBS leads to the conversion of LNGFR+ crest 
cells to LNGFR- cells. To test whether LNGFR+ cells are lost by selection or 
induction we performed a clonal analysis ofLNGFR+ founder cells initially plated 
under identical conditions and subsequently grown in the presence or absence of FBS. 
In this experiment individual LNGFR+ neural crest cells in clonal culture were 
identified and marked as described above. The founders were plated onto several 100 
mm dishes. A few hours after plating individual LNGFR + cells were identified and 
FBS was added to some of the dishes. Clones were allowed to grow for 7 days and 
then were analyzed for LNGFR expression. Examples of the resulting clones are 
shown in the micrographs of figure 4 (A-B). The results are graphically presented in 
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Figure 4. Primary LNGFR+ neural crest cells are sensitive to FBS. 
LNGFR+ neural crest cells taken from 1 day neural tube explants (A-D) or from 
8 day secondary mass cultures were grown as identified clones either in standard 
medium (A, B, E, F) or in standard medium supplemented with 10% FBS (C, D, G, 
H). Founder cells in all conditions were plated under identical conditions, identified as 
single LNGFR+ cells then switched to the experimental conditions. Shown are clones 
stained with monoclonal anti-LNGFR and a fluorescent secondary antibody (B, D, F, 





Figure 5. Quantification of serum sensitivity experiment. 
A. Primary LNGFR+ were grown for 7 days in either standard medium 
(hatched bars) or in standard medium supplemented with 10%FBS. The clones were 
then analyzed for LNGFR expression as previously described (Figure 2). 
B. LNGFR+ cells from secondary mass cultures of neural crest cells were 
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figure SA. We found that under both conditions (with and without 10% FBS) the 
cloning efficiency was high (-90%) but that in the presence ofFBS, 80% ofLNGFR+ 
founders produced clones in which no cell expressed LNGFR. By contrast, -50% of 
the founders grown without added FBS produced clones containing LNGFR 
expressing cells (i.e., both "LNGFR+" and "mixed" clones combined; see figure SA 
"LNGFR+" and "mixed" columns). Thus, primary LNGFR+ neural crest cells are 
sensitive to the presence of FBS. 
It has been well established that primary Schwann can grow in the presence of 
FBS and continue to express LNGFR under those conditions. It is possible that some 
founders producing "pure" clones when plated at day 8 (see the colony analysis 
described above) are actually committed Schwann cell blasts. If that is the case then we 
would not expect them to be sensitive to the presence of FBS. To test this notion we 
cloned neural crest cells late in culture and tested them for sensitivity to FBS. Primary 
neural crest cells were taken from 1 day old explants and cultured at a moderate density 
of- 5000 cells I 60 mm dish. After 7 days the cells were replated at clonal density onto 
100 mm dishes. A few hours after plating individual LNGFR+ cells were identified 
and inscribed as described above. To some dishes was added 10% FBS and all dishes 
were allowed to grow for an additional 7 days. The dishes were then analyzed for 
LNGFR expression. Examples of the resulting clones are shown in the micrographs of 
figure 4 (C-D). There are two majors results of this experiment. First, in contrast to 
the behavior ofLNGFR founders at day 1, more than 70% (Figure 5B, LNGFR+ and 
Mixed categories combined) of them produce clones containing LNGFR+ cells in the 
presence of FBS. Secondly, the FBS appears to have a trophic activity for the 
LNGFR+ founders, producing a cloning efficiency of -90% compared to- 50% in the 
absence of FBS. 
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Discussion 
We find that primary LNGFR+ neural crest cells tend to produce colonies 
comprised of both LNGFR+ and LNGFR- cells ("mixed" colonies). By contrast 
primary LNGFR- neural crest cells produce only "LNGFR-" clones. If, however, 
neural crest cells are allowed to grow in mass culture for -1 week before being plated at 
clonal densities, then the proportion of colonies comprised only of LNGFR+ cells 
("LNGFR+" colonies) increased substantially. In a serial sub-cloning analysis we 
show that single "mixed" clones can produce "mixed" and "LNGFR+" clones, as well 
as "LNGFR-" clones. Finally, we show that even though LNGFR+ founders of 
"mixed" clones, and LNGFR+ founders of pure "LNGFR+" clones are antigenically 
and morphologically indistinguishable, differences between them can be revealed by 
their differential sensitivity to FBS. "Mixed" founders in the presence ofFBS will, 
propagate and differentiate to form an LNGFR- clone. By contrast, "LNGFR+" 
founders, which probably represent Schwann cell blast cells, maintain LNGFR 
expression in FBS and propagate to form Schwann cells. FBS appears also to act as a 
trophic agent for these cells. Under Schwann cell differentiation conditions (described 
in Chapter 2) these cells will express the combination of 04 immunoreactivity and glial 
fibrillary acidic protein (GFAP) (not shown), i.e., they will differentiate into Schwann 
cells (Mirsky et al., 1990; Morgan et al., 1991). 
The sub-cloning experiments described here (like the sub-cloning experiments 
described in chapter 2) allow for the possibility that the observed heterogeneity of 
primary clones may result from the production of relatively restricted or committed cells 
from multipotent progenitors. An apparent inconsistency arises when one considers the 
sub-cloning of clones comprised purely of LNGFR+ cells. These clones contained 
cells that, upon sub-cloning, produced "mixed" secondary clones. A strong possibility 
is that the primary LNGFR+ founders, which form "mixed" and "LNGFR+" clones, 
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comprise a cell type distinct from LNGFR+ founders taken from day 8 cultures or 
primary clones. 
The LNGFR- cells that form under these conditions are most likely the same as 
the "0" cells described in chapter 2. These cells display a flattened fibroblastic 
morphology and fail to express neuronal and glial differentiation markers. Currently 
we cannot relate this cultured cell to any normal neural crest derivative. There are, 
however, several possibilities. We have observed under Schwann cell differentiation 
condition that some "0" cell will fuse to form multinucleate cells that twitch (not 
shown). These are probably striate muscle cells. They form from subclones of 
LNGFR+ founders that also produce glia, and thus do not represent somitic cell 
contaminants. The cephalic neural crest is known to produce mesectodermal cell types 
but the trunk neural crest is thought to have only a limited potential for mesectodermal 
differentiation. This very preliminary observation has been made on several occasions. 
No molecular markers of muscle differentiation were used but they may be used in the 
future and may reveal myogenic potential at early times, i.e., before fusion and 
twitching. Another possibility is that the "0" cell represent melanocytes or 
melanoblasts. Since the rats used in these experiments are albino, melanocyte 
formation is difficult to determine. It may be possible to use the monoclonal antibody 
TA99 to mark melanogenic cells in these cultures (Vijayasaradhi and Houghton, 1991). 
The cells may also represent fibroblasts, osteoblasts or chondrocytes. Specific marker 
for these cell types exist and should be applied to the "0" cells. If the "0" cells do 
represent a normal neural crest derivative then the fact that FBS is so effective in 
promoting its formation may provide some clue to the environmental control over the 
formation of those cells. 
Finally the findings presented in this appendix provide a useful assay for 
measuring the difference between two otherwise indistinguishable cell types, the neural 
crest stem cell and what may be a glial or glial-and-other blast cell. Current 
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investigations are underway to measure the transition from a serum-sensitive to a 
serum-dependent state, relative to the loss of neurogenic activity, as assayed by growth 
on a poly-D-lysine I fibronectin substrate. 
Experimental procedures 
Procedures used for this work are described in Chapter 2. 
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APPENDIX 2: Adrenergic differentiation and MASH-1 expression in 
cultures of rat neural crest cells 
with Alice Paquette 
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Introduction 
Lineage specification in the development of neural crest derivatives appears to 
be controlled by environmental factors present in anlage of specific derivative structures 
(Le Douarin, 1982). It is thought that the set of environments encountered by 
migrating neural crest cells are responsible for the specification of differentiated traits. 
This view derives in part from the observation that the founder cells of each class of 
neural crest derivative structure follow a distinct pathway of migration encountering a 
unique set of embryonic environments on the way to their ultimate destination. 
Sympathoadrenal precursors, for example, emerge from the neural crest, pass through 
the anterior part of the sclerotome, migrate past the ventral neural tube and notochord 
and ultimately arrive at the dorsal aorta where they undergo adrenergic and neuronal 
differentiation. The production of sympathoadrenal progenitors appears to be directed 
in part by the peri-aortic environment into which relatively undifferentiated neural crest 
cells migrate. In a study of Stern eta!. the necessity of notochord or ventral neural tube 
for the formation of adrenergic cells in the peri-aortic space is established by surgical 
removal of the notochord or inversion of the neural tube (Stern eta!., 1991). In vitro 
studies of the primary neural crest suggest that interaction with the semitic environment 
may be necessary for sympathoadrenal specification (Fauquet et al., 1981 ). There are 
several published cell culture studies in which specific environmental factors enhance 
adrenergic differentiation of primary neural crest cells. Maxwell et a!. found that an 
extract of EHS sarcoma significantly enhanced the production of adrenergic cells in 
secondary cultures of quail neural crest cells, apparently at the expense of melanocytes 
(Maxwell and Forbes, 1990). These authors also found that adrenergic differentiation 
was enhanced by culture at high cell density. Howard and Brenner-Fraser found that 
both a low-molecular weight component of chick embryo extract (CEE) and a soluble 
component of neural tube conditioned medium lead to the production of adrenergic cells 
in primary neural crest explants (Howard and Brenner-Fraser, 1985). Sieber-Blum 
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and Cohen found that CEE led to the generation of adrenergic cells in clonal cultures of 
quail neural crest cells (Sieber-Blum and Cohen, 1980). These authors also found that 
when the clones were grown on an extracellular matrix material taken from chick 
embryonic fibroblasts, both the number of adrenergic clones and the number of 
adrenergic cells per clone were increased. Others have described activities that enhance 
the production of adrenergic cells from developing neural crest derivatives, such as the 
DRG. Xue et al. found that insulin and IGF-1 enhance adrenergic differentiation in 
DRG cultures, but apparently do not have the same effect on primary neural crest cells 
(Xue et al., 1988). Finally, Fauquet et al. infected primary neural crest cells with a v-
myc oncogene containing virus (Fauquet et al., 1990). The expression of v-myc led to 
enhanced proliferation and adrenergic differentiation in a medium that is not otherwise 
permissive for adrenergic differentiation. Thus both external and internal factors can 
result in increased adrenergic differentiation among neural crest cells. The myc proto-
oncogene may normally participate in the expression of adrenergic traits, but it is 
expressed in a wide variety of cell types and may not provide specific information about 
adrenergic determination. 
A gene whose expression is fairly specific and may reflect determination of 
neural crest cells along an adrenergic pathway is the mammalian achete-scute homolog-
! gene (MASH-1). MASH-1 was identified by its homology with known neural 
determination genes in Drosophila melanogaster (Johnson et al., 1990). A member of 
the basic-helix-loop-helix family of transcription factors, MASH-1 may serve an 
important role in patterning of the nervous system by participation in neuronal cell type 
specification. MASH-1 was originally isolated from sympathoadrenal cells lines MAH 
and PC12. MASH-1 is expressed in the sympathetic ganglia at least a day before 
significant adrenergic differentiation takes place. MASH-1 is not expressed at any time 
in DRGs (Lo et al., 1991 ). MASH-1 may be an important transcription factor in the 
specification of adrenergic cells in the peripheral nervous system. 
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In order to define some of the factors necessary for the formation of adrenergic 
cells from neural crest cells, we developed a culture system for rat neural crest in which 
adrenergic differentiation could take place. In addition, we have studied the expression 
of MASH-1 in these cultures, both to relate its expression to the acquisition of 
adrenergic traits and to study environmental factors that may control MASH-1 
expression independent of adrenergic differentiation. 
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Results 
Culture conditions that promote expression of TH also promote MASH-1 expression. 
To study the formation of sympathoadrenal progenitors from primary neural 
crest we first needed to establish conditions that would promote the survival, growth 
and adrenergic differentiation of early neural crest cells. Culture conditions that satisfy 
these requirements have been described for avian neural crest. Similarly, conditions for 
the culture of mouse neural crest have also been described (Ito and Takeuchi, 1984; Ito 
et al., 1988). A screen of a variety of culture conditions revealed the following. In a 
relatively simple formulation of L-15C02, 10% fetal bovine serum (FBS), 10% chick 
embryo extract (CEE) neural crest cells migrated from the neural tube, proliferated 
extensively and within 5 days gave rise to some tyrosine hydroxylase (TH) expressing 
cells (not shown, however, Figure lA shows an example of the same cell type at a later 
time in culture, day 10). If either FBS or CEE was not included, neural crest cells 
migrated from neural tubes, but they did not proliferate extensively, nor did they form 
TH+ cells. In addition, cultures underwent extensive death by 5 days. The TH+ cells 
seen in the day 5 cultures were large diameter cells with a fibroblastic appearance and 
were probably not sympathoadrenal progenitors (Birren and Anderson, 1990). In a test 
of other conditions, at later times in culture, we found that two other TH+ cell types 
would form. 
Primary neural crest cells were grown at high cell density in the medium 
described above for 5 days. The medium was then exchanged either with medium 
supplemented with basic fibroblast growth factor (FGF) and dexamethasone (DEX) or 
with medium lacking CEE and supplemented with FGF and DEX. Three distinct TH+ 
cell types emerged after 10 days in culture. The fibroblastic TH+ cell type (the same 
cell type as was seen in day 5 cultures) was found in the regions of the dish with the 
lowest cell density (Figure IA, B). In the high density regions two other TH+ cell 
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types were found in clusters. Some clusters were comprised of process bearing cells 
with a relatively low-level of TH (Figure 1 C, D). The other cluster type contained cells 
with short processes expressing high-levels of TH (Figure lE, F). This cell type 
resembled the sympathoadrenal progenitor both in its morphology and level of TH 
expression. If the medium was exchanged at day 5 for medium lacking CEE but 
supplemented with bFGF and dexamethasone, the fibroblastic TH+ cell was not 
observed but the other two TH+ cell types were generated. TH was never expressed in 
a high percentage of the cells. TH+ cells probably represented -0.1% of the total cell 
population at day 10 of culture. A few general qualitative observations from these 
experiments are: 1) Expression of TH in the fibroblastic cell appears to require low 
cell density and the presence of both CEE and FBS. 2) Expression of THin both 
process-bearing cells and sympathoadrenal-like cells appears to require high cell 
density, FGF, DEX, and FBS, but does not require CEE in the last 5 days of culture. 
3) If at day 5 the CEE was removed, by day 10 very few TH+ cells remained. Those 
that did remain, however, were found only in the most dense regions of the culture and 
were all of the low-TH+ process bearing type. 
To establish a relationship between MASH-1 expression and TH expression, 
cultured neural crest cells were double-labeled with antibodies at various times in TH 
promoting conditions. After 5 days in culture (in L-15 C02, 10%FBS, 10%CEE, 
FGF and DEX), cells were found to express MASH-I but very few TH+ cells were 
observed (not shown). By day 10 of culture both TH+ and MASH-1 +cells were 
found in the cultures (Figure 2A,B). Some of the TH+ cells also expressed MASH-1 
(Figure 2C). Moreover, TH+ cells were found clustered with MASH-1 +cells (Figure 
3). Cultures grown without added FGF and DEX appeared to produce fewer MASH-
I+ cells both at day 5 and at day 10. Adrenergic differentiation was very limited under 
those conditions. These results are summarized in table I. 
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Figure 1. TH expression in day 10 cultures. 
Cultures of neural crest cells were grown for 5 days in L-15C02, 1 O%CEE, 
10%FBS then were supplemented with FGF (50ng/ml) and DEX (5j..LM) and grown for 
an additional 5 days. Three distinct TH+ cell types can be found . (A, B) flat, 
fibroblastic TH+ cells appear at the margins of the culture. (C, D) rn+ process 
bearing cells can be found in dense regions. (E, F) high-level TH expressing cells, 
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Figure 2. TH and MASH-1 expression in day 10 cultures. 
Cultures were grown as described for figure 1, were stained for both TH and 
MASH-1 expression, and then were counterstained with the DNA dye DAPI to reveal 
cell nuclei. Panel A shows cell number by nuclear DAPI fluorescence (blue). Panel B, 
TH (green) and MASH-1 (black) are revealed by immunocytochemistry for the same 
field shown in panel A. Panel C, another field shows the coincidence of MASH-1 and 
TH in individual cells. 
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Figure 3. TH and MASH-I expression in day 10 cultures. 
Lower magnification images taken from cultures like those described in figure 2 
reveal that TH expression and MASH-1 expression is clustered within dense regions of 
the culture. Panel A shows DAPI nuclear fluorescence. Panel B shows TH (green) 
and MASH-1 (black) immunoreactivity. 
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Table I. TH and MASH-1 expression. 
The expression ofTH and MASH-1 was tested in day 5 and day 10 cultures of 
primary neural crest. Cultures were grown in either standard medium, consisting of L-
15C02, 10% FBS, 10%CEE (Std. Med.) or standard medium supplemented with 50 
ng/rnl bFGF and 51lM dexamethasone (+F+D). Culture were qualitatively scored on 
the basis of apparent proportions of stained cells to the total number of cells. Three 
types of ru+ cell were observed, a flattened fibroblastic cell (Flat), process bearing 
low-ru+ cells (PB), and sympathoadrenal-like cells (SA). 
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MASH -1 expression precedes the expression of adrenergic traits in this culture 
system. In some cases MASH-1 and TH are expressed in the same cells in day 10 
cultures. Furthermore, their coincident expression is also observed as clusters of 
stained cells separated by unstained cells in high density cultures. Finally, conditions 
that favor the production of rn+ cells also enhance the expression of MASH-1. In 
vivo, MASH-1 is expressed in developing sympathetic ganglia by E11.5 and TH first 
appear at- E12 (Lo, et al., 1991). The neural crest that is used in these experiments is 
taken from E10.5 animals. Thus the expression of the two markers in this culture 
system is extremely delayed relative to the normal in vivo timing. Given the fact that 
expression of MASH-1 precedes expression of THin this system, added to the fact that 
TH and MASH are sometimes co-expressed we sought to ask whether conditions that 
promote early expression of MASH-1 (e.g., by day 2 in culture) also promote TH 
expression at an earlier time. 
MASH-1 expression in primary neural crest cells can be controlled by several 
environmental factors. 
Several conditions were tested for their ability to enhance MASH-1 expression 
in day 2 cultures and to produce adrenergic cells at later times. Initially, we found that 
both CEE and FBS were necessary for survival and growth of neural crest cells. We 
therefore developed a chemically defined medium (DM) (this chemically defined 
medium is described in chapter 2) in which neural crest cells could migrate from neural 
tubes, propagate and survive for a period at least corresponding to the time of maximal 
adrenergic expression, i.e., at least 10 days. This medium could then be used as a 
basal medium, to which other factors, e.g. FBS and CEE, could be added to test their 
effect on the expression ofTH and MASH-1. The factors that were tested were FBS, 
CEE, DEX, FGF, nerve growth factor (NGF), and retinoic acid (RA). 
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The first experiment was designed to examine the effects of the different culture 
conditions on the expression of MASH-1 after 2 days of culture. That is we tested the 
factors for their ability to promote the early expression of MASH-I. In this experiment 
neural tubes were plated initially in 4 different culture media (Table II). After 24 hours 
the neural tubes were scraped away from the neural crest cells, and the crest cells were 
removed from the dish by trypsin treatment and replated into 2 dishes for each 
condition. After an additional culture period of 24 hours the cells were fixed and 
stained for MASH-I and TH. In none of the conditions was TH expressed at that time 
in culture. In DM alone the neural tubes attached and appeared healthy after 24 hours, 
but no neural crest cell migrated from the neural tube. In the other three conditions 
there was robust neural crest cell migration, as measured by the number of cells 
recovered from an equivalent total length of neural tube (Table II). The MASH-1 
expression results were quantified and are presently in Table II. The proportion of 
MASH-1+ cells was 4-5 times greater in OM with FGF and NGF than in any other 
condition. It appears that CEE inhibits high level MASH-I expression in these cells. 
It was shown previously that retinoic acid can induce MASH-I expression in 
P19 embryonic carcinoma cells (Johnson et al., 1992). Retinoic acid is a component of 
the DM, so we tested the expression of MASH-1 as a function of RA concentration in 
secondary cultures of neural crest cells. Neural tubes were initially plated in DM 
without RA for 24 hours. The crest cells were then replated and grown for 2 days 
more under a series of RA concentrations. The expression of MASH-I was the 
quantified. In noRA, 1.6 ± 0.49 % of the crest cells expressed MASH-1. RA 
concentrations ranging from lQ-8 M to lQ-6 M were tested and all gave about the same 
level of MASH-1 expression: at 1o-8 M RA, 19 ± 2.7 % of the neural crest cell 
expressed MASH-1 (Figure 4A). Micrographs of neural crest cells grown in noRA 
(Figure 4D,E) and in lQ-8 M RA (Figure 4B,C) stained for MASH-I immunoreactivity 
and counterstained with DAPI are given as examples. The staining in MASH-1 + cells 
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Table II. Conditions of short term neural crest culture. 
The expression ofTH and MASH-1 was tested during short term (48 hour) 
growth in various compositions of culture medium. Neural tubes were plated in 4 
different media, allowed to grow for 24 hours. Neural tubes were scraped away, 
neural crest cells were harvested, counted (column 2) and replated according to 
columns 3. "DM" is defined medium lacking FGF and NGF (Chapter 2). "N" is NGF 
at a concentration of 1 IJ.g/ml. "F" is bFGF at a concentration of 50 ng/rnl. "CEE" is 
10% chick embryo extract. MASH -1 ex pression was measured as a proportion of 
MASH-1 +cells to the total number of cells (Column 4). Errors indicated are the 
standard error of the mean (s.e.m.) (n=2, except for condition 4, where n=3). 
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MASH-1 expm at 
day2 
(% total ± s.e.m.) 
4.2 ± 4.2 
24.1 ±0.1 
4.1 ± 0.4 
6.2 ± 0.6 
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Figure 4. Retinoic acid dependence of MASH-1 expression. 
Neural tubes were plated in defined medium containing FGF and NGF 
(DM+N+F) but lacking retinoic acid (RA). After 24 hours the neural tubes were 
scraped away, neural crest cells were harvested and replated into various concentrations 
of RA containing DM+N+F. After an additional 48 hours of growth, cultures were 
fixed, stained for MASH-1 and counterstained with DAPI. Three dishes from each of 
the conditions were counted. DAPI stained cells were counted for total cell number and 
MASH-1 + cells were scored by presence of nuclear staining. In panel A, the percent 
MASH-1 + ± s.e.m. is graphed for each concentration of RA. In panels B-E example 
fields from cultures of two different RA concentrations are shown. Panel B shows 
MASH-1 immunoreactivity in lOnM RA; the corresponding DAPI staining is shown in 
panel C. Note that cells expressing MASH-1 do not show DAPI fluorescence. Panel 
D shows MASH-1 immunoreactivity in 0 RA; the corresponding DAPI staining is 
shown in panel E. 
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was found to obscured the DAPI fluorescence. Total cell number did not significantly 
vary between cultures grown with different RA concentrations, nor did overt 
appearance of the cells. TH was not expressed in any cell under these conditions. 
Culture conditions were then tested for their effect on TH expression at day 5 
and day IO. The conditions used in this experiment are outlined in Table III. Neural 
tubes were plated in the one medium formulation for the first day (Table III, Column 
I), then neural crest cells were replated in a second medium formulation (Table III, 
Column 2) and allowed to grow for 4 days. At this point, one group of cultures (day 5 
cultures) was fixed and stained for MASH-I expression. The medium in the remaining 
group (day 10 cultures) of cultures was exchanged (Table III, Column 3). These 
cultures were allowed to grow for an additional 5 days, then were fixed and stained for 
MASH-I and TH expression. MASH-1 was expressed in all day 5 cultures. CEE 
appeared to decrease the proportion of MASH-I+ cells. CEE also appeared to inhibit 
neuron formation, as judged morphologically. In day 10 cultures we found that all 
conditions produced a large number of MASH-1 +cells. We found that brightly-rn+, 
SA-like cells, were present in large numbers in condition 1, and in all conditions 
containing CEE for the first 5 days of culture. Under condition 1, where cells were 
grown with the chemically defined medium supplemented with FBS, SA-like cells were 
present in high numbers at day 10. When either DEX or FGF or both were added to 
the medium (Table III, conditions 2, 3 and 4) the number of SA-like cells was 
dramatically reduced. This result appears to be contrary to results (see Table I) 
obtained with CEE present either during the first 5 days or throughout the culture 
period in which FGF and DEX enhance adrenergic differentiation. 
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Table TIL Culture conditions for long term growth of neural crest cells 
Neural crest cell secondary cultures were established from neural tube explants 
grown in the medium described in column 2. During the second 4 days, cultures were 
grown in the medium described in column 3. The medium was then switched and the 
cultures were grown for the last 5 day in the medium described in column 5. The 
medium components are the same as in Table I with the addition: "L-15" is L-15 C02 
(see Chapter 2) and "FBS"; 10% fetal bovine serum; and "D" is 5 ).lM dexamethasone. 
The expression of MASH-1 at day 5 and day 10 of culture, and TH at day 10 of culture 























































































































































































































































































MASH-I is expressed by neural crest cell clones under environmental conditions that 
favor neuronal differentiation. 
As reported elsewhere (see chapter 2), the fate of primary neural crest cell 
clones can be directed by the substrate on which they are grown. Specifically, primary 
neural crest cell clones grown on poly-D-lysine (pDL) and fibronectin (FN) generate 
peripheral neurons, glia and other cells. When clones are grown on only FN, 
however, they do not generate neurons. The expression of MASH-1 was tested under 
these two conditions. Clones were allowed to grow for IO days on pDL/FN or on FN 
in a medium formulation (DM, IO% CEE, FGF, NGF) previously described to allow 
multipotent neural crest cells to generate neurons and glia in clonal culture. When 
clones were examined for MASH-I expression, we found that clones grown on FN 
produced no MASH-I+ cells (Figure 5D, E, F). On the other hand, every clone grown 
on pDL/FN produced some MASH-1 + cells (Figure SA, B, C). Moreover, some 
MASH-1 process bearing cells were present in this condition (Figure 6). Adrenergic 
differentiation was not observed in either condition. Hence, a condition that favors 
neuron production in clonal culture also favors the expression of MASH-1 in neural 
crest cells. 
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Figure 5. Substrate dependence of MASH-1 expression in clonal culture. 
Neural crest cell clones were grown for 10 days in DM+CEE on either poly-D-
lysine I fibronectin (A-C), or on fibronectin only. The clones were fixed, stained for 
MASH-1 (B, E) and counterstained with DAPI (C, F). Phase contrast images of the 
clones are shown (A, D). No MASH-I expressing cells were found on FN in these 
clonal cultures. 
\ . 




















, • ~ 
' ... 
180 
Figure 6. MASH-I can be expressed by neurons. 
Clones grown on pDUFN as described in figure 6. Were often found to have 
MASH-1 + neurons in then. Shown here is a region of one such clone in phase-




Control of adrenergic differentiation is complex. We can, however, draw 
some general conclusions about conditions needed forTH expression and about the 
relationship between MASH-1 expression and TH expression. Under conditions that 
promote expression of THin neural crest cells, MASH-1 is always expressed and 
always expressed before THis expressed. It is not clear whether MASH-1 expression 
is a necessary prerequisite of TH expression, but TH and MASH-1 are frequently 
expressed in the same cells. This observation is consistent with the in vivo 
observations of Lo et al. (Lo, et al., 1991). Conditions that prevent or delay neuronal 
differentiation, i.e., CEE in the culture medium, also severely suppress MASH-1 
expression. Conditions that promote strong expression of.MASH-1 also promote 
neuronal differentiation but do not necessarily lead to TH expression. Neural crest cells 
express high levels of MASH-1 in response to RA, for example, but subsequent 
expression of THis not observed. Hence, MASH-1 expression is not sufficient for 
adrenergic differentiation. A precise understanding of the relationship between MASH-
I expression and adrenergic or neuronal differentiation will have to await the generation 
of reagents to disrupt the normal function of MASH -1 . 
The results of Stern et al., indicate that either the floor plate or notochord is 
necessary, but neither are sufficient for adrenergic differentiation of neural crest cells in 
the periaortic environment (Stern, et al., 1991). The floor plate has been shown to be 
sources of retinoids (Wagner et al., 1990). In addition Placzek has shown, in a co-
culture experiment, that notochord can induce MASH-1 expression in lateral neural 
plate (Dr. Marysia Placzek, personal communication). It may be that the adrenergic 
differentiation of neural crest cells requires a series of specific environmental signals. 
For example, undifferentiated migrating neural crest cells encounter a MASH-1 
inducing signal, e.g., retinoids from the notochord or floor plate, then another signal, 
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perhaps derived from the dorsal aorta, promotes the later stages of adrenergic 
differentiation. The nature of such a late signal remains to be determined. 
The sequence of embryonic environments encountered by migrating neural crest 
cells may specify adrenergic differentiation in a sequential fashion. The growth of 
neural crest cells in a chemically defined medium in co-culture with other embryonic 
structures, such as notochord, ventral neural tube, dorsal aorta and somite may be 
useful for testing which structures are necessary for adrenergic differentiation and in 
what order they must act. The early expression of MASH-1 may be of use to determine 
which environments must be encountered first to ultimately express TH. 
Experimental Procedures 
The experimental procedures used in this work are described in Chapter 2. 
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